| C01946 |
Oleandomycin; Amimycin; Landomycin; Matromycin; Romicil |
(P) unclassified |
| C04931 |
Argatroban; (2R,4R)-4-Methyl-1[Nalpha-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperadinecarboxylic acid |
(P) unclassified |
| C06174 |
Codeine; (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol |
(P) unclassified |
| C07005 |
Flunisolide; Flunisolide anhydrous |
(P) unclassified |
| C07051 |
Indinavir |
(P) unclassified |
| D00066 |
Progesterone (JP18/USP/INN); Crinone (TN); Prometrium (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00067 |
Estrone (JAN/USP/INN); Estrone (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00085 |
Insulin (JAN/USP) |
(P) unclassified |
| D00105 |
Estradiol (JAN/USP/INN); Climara (TN); Divigel (TN); Estrace (TN); Estraderm (TN); Estrasorb (TN); Estring (TN); Estrogel (TN); Innofem (TN); Vagifem (TN); Vivelle (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00106 |
Epoprostenol (USAN/INN); Prostaglandin I2; Prostacyclin; Epoprostenol (TN) |
(P) unclassified |
| D00107 |
Tacrolimus (USP/INN); Tacrolimus hydrate (JP18); Prograf (TN); Protopic (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00109 |
Aspirin (JP18/USP); Aspalon (JAN); Acetylsalicylic acid; Easprin (TN); Durlaza (TN) |
(P) unclassified |
| D00123 |
Cyanamide (JP18); Cyanamide (TN) |
(CI) unclassified |
| D00124 |
Ephedrine (USP); Ephedrine (TN) |
(P) unclassified |
| D00127 |
Piroxicam (JP18/USP/INN); Feldene (TN) |
(P) unclassified |
| D00130 |
Diflunisal (JAN/USP/INN); Dolobid (TN) |
(P) unclassified |
| D00131 |
Disulfiram (JP18/USP/INN); Antabuse (TN) |
(CI) unclassified |
| D00136 |
Haloperidol (JP18/USP/INN); Haldol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00140 |
Erythromycin (JP18/USP/INN); Akne-mycin (TN); Eryc (TN); Erygel (TN); Pce (TN); Staticin (TN); T-stat (TN) |
(P) unclassified |
| D00168 |
Cytarabine (JP18/USP/INN); ARA-C; Depocyt (TN) |
(P) unclassified |
| D00181 |
Argatroban (USP); Argatroban hydrate (JP18); Novastan (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00184 |
Cyclosporine (USP); Ciclosporin (JP18); Gengraf (TN); Neoral (TN); Restasis (TN); Sandimmune (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00186 |
Ciprofloxacin (JP18/USP/INN); Cipro (TN); Otiprio (TN) |
(P) unclassified |
| D00195 |
Codeine (USP); Codeine hydrate |
(P) unclassified |
| D00197 |
Reserpine (JP18/USP/INN); Apoplon (TN); Serpalan (TN) |
(P) unclassified |
| D00198 |
Rescinnamine (JAN/INN); Tsuruselpi S (TN) |
(P) unclassified |
| D00203 |
Amphotericin B (JP18/USP/INN); Ambisome (TN); Amphotec (TN); Fungizone (TN) |
(P) unclassified |
| D00210 |
Norfloxacin (JP18/USP/INN); Noroxin (TN) |
(P) unclassified |
| D00211 |
Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) |
(P) CYP induction: CYP3A4 |
| D00216 |
Acarbose (JAN/USAN/INN); Precose (TN) |
(P) unclassified |
| D00218 |
Acetazolamide (JP18/USP/INN); Diamox (TN) |
(P) unclassified |
| D00219 |
Acetohexamide (JP18/USP/INN); Dymelor (TN) |
(P) unclassified |
| D00246 |
Budesonide (JP18/USP/INN); Entocort EC (TN); Pulmicort (TN); Rhinocort (TN); Uceris (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D00247 |
Bumetanide (JP18/USP/INN); Bumex (TN) |
(P) unclassified |
| D00252 |
Carbamazepine (JP18/USP/INN); Equetro (TN); Tegretol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00255 |
Carvedilol (JP18/USP/INN); Artist (TN); Coreg (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00271 |
Chlorpropamide (JP18/USP/INN); Diabinese (TN) |
(P) unclassified |
| D00272 |
Chlorthalidone (USP); Chlortalidone (JAN/INN); Hygroton (TN); Thalitone (TN) |
(P) unclassified |
| D00276 |
Clarithromycin (JP18/USP/INN); Biaxin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00281 |
Clonidine (JAN/USP/INN); Catarpres-TTS (TN) |
(P) unclassified |
| D00282 |
Clotrimazole (JP18/USP/INN); Lotrimin (TN); Mycelex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00283 |
Clozapine (JAN/USP/INN); Clozaril (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00287 |
Cyclophosphamide (USP); Cyclophosphamide hydrate (JP18); Cytoxan (TN); Neosar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00292 |
Dexamethasone (JP18/USP/INN); Decadron (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D00293 |
Diazepam (JP18/USP/INN); Diastat (TN); Valium (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00294 |
Diazoxide (JAN/USP/INN); Hyperstat (TN); Proglycem (TN) |
(P) unclassified |
| D00298 |
Digoxin (JP18/USP); Lanoxicaps (TN); Lanoxin (TN) |
(P) unclassified |
| D00302 |
Dipyridamole (JP18/USP/INN); Persantine (TN) |
(P) unclassified |
| D00303 |
Disopyramide (JP18/USAN/INN); Rythmodan P (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00312 |
Estrone sodium sulfate; Sodium estrone sulfate |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00313 |
Ethacrynic acid (USP); Etacrynic acid (JP18/INN) |
(P) unclassified |
| D00319 |
Felodipine (JP18/USP/INN); Plendil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00320 |
Fentanyl (JAN/USP/INN); Duragesic (TN); Subsys (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00321 |
Finasteride (JAN/USP/INN); Propecia (TN); Proscar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00322 |
Fluconazole (JP18/USP/INN); Diflucan (TN) |
(P) CYP inhibition: CYP3A4 |
| D00324 |
Flunisolide (JAN/USP); Aerospan (TN); Nasalide (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D00330 |
Flurbiprofen (JP18/USP/INN); Ansaid (TN) |
(P) unclassified |
| D00331 |
Furosemide (JP18/USP/INN); Frusemide; Lasix (TN) |
(P) unclassified |
| D00335 |
Glipizide (USP/INN); Glucotrol (TN) |
(P) unclassified |
| D00336 |
Glyburide (USP); Glibenclamide (JP18/INN); Diabeta (TN); Glynase (TN); Micronase (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00340 |
Hydrochlorothiazide (JP18/USP/INN); Esidrix (TN); Microzide (TN) |
(P) unclassified |
| D00343 |
Ifosfamide (JAN/USP/INN); Ifex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00345 |
Indapamide (JP18/USP); Lozol (TN); Natrix (TN) |
(P) unclassified |
| D00350 |
Itraconazole (JP18/USP); Itrizole (TN); Sporanox (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00351 |
Ketoconazole (JP18/USP); Nizoral (TN); Xolegel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00355 |
Lansoprazole (JP18/USP/INN); Prevacid (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00358 |
Lidocaine (JP18/USP/INN); Dentipatch (TN); Xylocaine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00359 |
Lovastatin (USP/INN); MK-803; ML-530B; Mevacor (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00364 |
Loratadine (JAN/USP/INN); Claritin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00372 |
Thiabendazole (USP); Tiabendazole (JAN/INN); Mintezol (TN) |
(P) unclassified |
| D00377 |
Mesalamine (USP); Mesalazine (JP18/INN); Apriso (TN); Asacol (TN); Canasa (TN); Delzicol (TN); Lialda (TN); Mesalamine (TN); Pentasa (TN); Rowasa (TN); Sfrowasa (TN) |
(P) unclassified |
| D00379 |
Tolazamide (JAN/USP/INN); Tolinase (TN) |
(P) unclassified |
| D00380 |
Tolbutamide (JP18/USP/INN); Orinase (TN) |
(P) unclassified |
| D00382 |
Torsemide (USP); Torasemide (JAN/INN); Demadex (TN); Luprac (TN) |
(P) unclassified |
| D00386 |
Triamterene (JP18/USP/INN); Dyrenium (TN) |
(P) unclassified |
| D00387 |
Triazolam (JP18/USP/INN); Halcion (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00395 |
Troglitazone (JAN/USAN/INN); Rezulin (TN) |
(P) unclassified |
| D00405 |
Methyldopa (USP); Methyldopa hydrate (JP18); Aldomet (TN) |
(P) unclassified |
| D00407 |
Methylprednisolone (JP18/USP/INN); Medrol (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D00416 |
Miconazole (JP18/USP/INN); Monistat (TN); Oravig (TN) |
(P) unclassified |
| D00418 |
Minoxidil (JAN/USP/INN); Loniten (TN); Riup (TN); Rogaine (TN) |
(P) unclassified |
| D00420 |
Mitotane (JAN/USP/INN); Lysodren (TN) |
(P) unclassified |
| D00424 |
Rifabutin (JAN/USP/INN); Mycobutin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00426 |
Risperidone (JP18/USP/INN); Risperdal (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00427 |
Ritonavir (JAN/USP/INN); Norvir (TN) |
(P) unclassified |
| D00428 |
Salsalate (USP/INN); Sasapyrine (JAN); Disalcid (TN) |
(P) unclassified |
| D00429 |
Saquinavir (JAN/USP/INN); Fortovase (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00431 |
Metolazone (JAN/USP/INN); Zaroxolyn (TN) |
(P) unclassified |
| D00434 |
Simvastatin (JP18/USP/INN); MK-733; Zocor (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00437 |
Nifedipine (JP18/USP/INN); Adalat (TN); Afeditab CR (TN); Procardia (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00438 |
Nimodipine (USP/INN); Nimotop (TN); Nymalize (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00443 |
Spironolactone (JP18/USP/INN); Aldactone (TN) |
(P) unclassified |
| D00448 |
Sulfasalazine (USP/INN); Salazosulfapyridine (JP18); Azulfidine (TN) |
(P) unclassified |
| D00453 |
Ofloxacin (JP18/USP/INN); Floxin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00455 |
Omeprazole (JP18/USP/INN); Prilosec (TN) |
(P) unclassified |
| D00456 |
Ondansetron (JAN/USP/INN); Zofran ODT (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00457 |
Quazepam (JAN/USP/INN); Doral (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00458 |
Quetiapine fumarate (JP18/USP); Seroquel (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00461 |
Quinethazone (JAN/INN); Hydromox (TN) |
(P) unclassified |
| D00465 |
Oxybutynin (USAN/INN); Anturol (TN); Oxytrol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00471 |
Praziquantel (JAN/USP/INN); Biltricide (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00483 |
Propranolol hydrochloride (JP18/USP); Inderal (TN); Innopran XL (TN) |
(P) unclassified |
| D00491 |
Paclitaxel (JAN/USP/INN); Abraxane (TN); Taxol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00506 |
Phenobarbital (JP18/USP/INN); Luminal (TN) |
(P) unclassified |
| D00512 |
Phenytoin (JP18/USP/INN); Dilantin (TN) |
(P) unclassified |
| D00519 |
Chlorothiazide (JAN/USP/INN); Diuril (TN) |
(P) unclassified |
| D00528 |
Caffeine (USP); Anhydrous caffeine (JP18); Anhydrous caffeine (TN); Respia (TN) |
(P) unclassified |
| D00529 |
Montelukast sodium (JP18/USP); Singulair (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00530 |
Zaleplon (JAN/USP/INN); Sonata (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00537 |
Topiramate (JAN/USP/INN); Topamax (TN); Trokendi xr (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00539 |
Ethosuximide (JP18/USP/INN); Zarontin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00542 |
Halothane (JP18/USP/INN); Fluothane (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00544 |
Methoxyflurane (USP/INN); Penthrane (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00554 |
Ethinyl estradiol (USP); Ethinylestradiol (JP18/INN); Estinyl (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00560 |
Pimozide (JP18/USP/INN); Orap (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00563 |
Mirtazapine (JAN/USP/INN); Remeron (TN); Reflex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00564 |
Warfarin sodium (USP); Coumadin (TN); Jantoven (TN) |
(P) unclassified |
| D00566 |
Sodium salicylate (JP18/USP); Salsonin (TN) |
(P) unclassified |
| D00570 |
Colchicine (JP18/USP); Colchicine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00578 |
Voriconazole (JP18/USP/INN); Vfend (TN) |
(P) unclassified |
| D00585 |
Mifepristone (JAN/USAN/INN); Korlym (TN); Mifeprex (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D00588 |
Levofloxacin (USP); Levofloxacin hydrate (JP18); Levofloxacin hemihydrate; Iquix (TN); Levaquin (TN); Quixin (TN) |
(P) unclassified |
| D00592 |
Dapsone (USP); Diaphenylsulfone (JAN); Aczone (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00593 |
Glimepiride (JP18/USP/INN); Amaryl (TN) |
(P) unclassified |
| D00594 |
Repaglinide (JAN/USP/INN); Prandin (TN); Surepost (TN) |
(P) unclassified |
| D00595 |
Buformin (USAN/INN) |
(P) unclassified |
| D00596 |
Rosiglitazone maleate (JAN/USP); Avandia (TN) |
(P) unclassified |
| D00604 |
Clonidine hydrochloride (JP18/USP); Nexiclon (TN); Kapvay (TN); Duraclon (TN); Catapres (TN) |
(P) unclassified |
| D00606 |
Guanfacine hydrochloride (JAN/USP); Intuniv (TN); Tenex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00608 |
Doxazosin mesylate (USP); Doxazosin mesilate (JP18); Cardura (TN) |
(P) unclassified |
| D00609 |
Prazosin hydrochloride (JP18/USP); Minipress (TN) |
(P) unclassified |
| D00611 |
Mecamylamine hydrochloride (USP); Inversine (TN) |
(P) unclassified |
| D00612 |
Trimetaphan camsilate (JAN/INN); Trimetaphan camsylate; Arfonad (TN) |
(P) unclassified |
| D00614 |
Sodium nitroprusside (USP); Sodium nitroprusside hydrate (JAN); Nitropress (TN) |
(P) unclassified |
| D00615 |
Amlodipine besylate (USP); Amlodipine besilate (JP18); Norvasc (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00616 |
Diltiazem hydrochloride (JP18/USP); Cardizem (TN); Cartia XT (TN); Dilacor XR (TN); Dilt-CD (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00617 |
Nicardipine hydrochloride (JP18/USAN); Cardene (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00618 |
Nisoldipine (JAN/USAN/INN); Sular (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00619 |
Verapamil hydrochloride (JP18/USP); Calan (TN); Covera-hs (TN); Vasolan (TN); Verelan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00625 |
Miglitol (JP18/USAN/INN); Glyset (TN) |
(P) unclassified |
| D00629 |
Nitrendipine (JP18/USAN/INN); Baypress (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00631 |
Bepridil hydrochloride (USAN); Bepridil hydrochloride hydrate (JAN); Vascor (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00636 |
Amiodarone hydrochloride (JP18/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00637 |
Disopyramide phosphate (JAN/USP); Norpace (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00640 |
Propafenone hydrochloride (JP18/USP); Rythmol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00646 |
Tolterodine (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00649 |
Amiloride hydrochloride (USP); Midamor (TN) |
(P) unclassified |
| D00650 |
Bendroflumethiazide (JAN/USP/INN); Naturetin (TN) |
(P) unclassified |
| D00651 |
Benzthiazide (JAN/INN); Exna (TN) |
(P) unclassified |
| D00653 |
Dorzolamide hydrochloride (JP18/USP); Trusopt (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00654 |
Hydroflumethiazide (JAN/USP/INN); Saluron (TN) |
(P) unclassified |
| D00656 |
Methyclothiazide (JAN/USP/INN); Enduron (TN) |
(P) unclassified |
| D00657 |
Polythiazide (JAN/USAN/INN); Renese (TN) |
(P) unclassified |
| D00658 |
Trichlormethiazide (JP18/USP/INN); Naqua (TN) |
(P) unclassified |
| D00661 |
Cevimeline hydrochloride (USAN); Cevimeline hydrochloride hydrate (JAN); Evoxac (TN); Saligren (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00670 |
Donepezil hydrochloride (JP18/USP); Aricept (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00674 |
Naratriptan hydrochloride (JAN/USP); Amerge (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00677 |
Granisetron hydrochloride (JAN/USP); Kytril (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00678 |
Ondansetron hydrochloride hydrate (JAN/USP); Ondansetron hydrochloride; Zofran (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00679 |
Ergotamine tartrate (JP18/USP); Ergomar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00680 |
Methylergonovine maleate (USP); Methylergometrine maleate (JP18); Methergine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00683 |
Albuterol sulfate (USP); Salbutamol sulfate (JP18); Accuneb (TN); Proventil (TN); Ventolin (TN) |
(P) unclassified |
| D00687 |
Salmeterol xinafoate (JAN/USP); Serevent (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00688 |
Terbutaline sulfate (JP18/USP); Brethine (TN) |
(P) unclassified |
| D00689 |
Beclomethasone dipropionate (USP); Beclometasone dipropionate (JP18); Beclovent (TN); Qnasl (TN); Vanceril (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D00690 |
Mometasone furoate (JAN/USP); Asmanex (TN); Elocon (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D00696 |
Midazolam hydrochloride (USAN); Versed (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) unclassified |
| D00706 |
Zolpidem tartrate (JP18/USP); Ambien (TN); Intermezzo (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00722 |
Oxybutynin chloride (USP); Oxybutynin hydrochloride (JP18); Ditropan (TN); Gelnique (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00724 |
Rabeprazole sodium (JP18/USP); Aciphex (TN); Pariet (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00727 |
Olsalazine sodium (USAN); Dipentum (TN) |
(P) unclassified |
| D00729 |
Loperamide hydrochloride (JAN/USP); Imodium (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00749 |
Leflunomide (JAN/USP/INN); Arava (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00751 |
Methylprednisolone sodium succinate (JAN/USP); A-methapred (TN); Solu-medrol (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D00753 |
Sirolimus (JAN/USAN/INN); Rapamune (TN); Rapamycin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00754 |
Thalidomide (JAN/USP/INN); Thalomid (TN); Thaled (TN) |
(P) unclassified |
| D00762 |
Metyrosine (USP); Metirosine (JAN/INN); Demser (TN) |
(P) unclassified |
| D00765 |
Rocuronium bromide (JAN/USP/INN); Zemuron (TN) |
(P) unclassified |
| D00769 |
Clopidogrel bisulfate (USP); Clopidogrel sulfate (JP18); Clopidogrel sulfate tablets (JP18); Clopidogrel hydrogen sulphate; Isocover (TN); Plavix (TN) |
(P) unclassified |
| D00780 |
Bromocriptine mesylate (USP); Bromocriptine mesilate (JP18); Parlodel (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00785 |
Selegiline hydrochloride (JAN/USP); Eldepryl (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00794 |
Loxapine succinate (USP); Loxitane (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00804 |
Ivermectin (JAN/USP/INN); Sklice (TN); Soolantra (TN); Stromectol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00809 |
Amitriptyline hydrochloride (JP18/USP); Elavil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00810 |
Choline salicylate (JAN/USAN/INN); Arthropan (TN) |
(P) unclassified |
| D00811 |
Clomipramine hydrochloride (JP18/USP); Anafranil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00815 |
Imipramine hydrochloride (JP18/USP); Tofranil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00820 |
Trazodone hydrochloride (JAN/USP); Desyrel (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00821 |
Venlafaxine hydrochloride (JAN/USP); Effexor (TN) |
(P) unclassified |
| D00822 |
Citalopram hydrobromide (USP); Celexa (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00825 |
Sertraline hydrochloride (JAN/USP); Zoloft (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00827 |
Magnesium salicylate (USP); Magnesium salicylate tetrahydrate; Magan (TN) |
(P) unclassified |
| D00831 |
Mefloquine hydrochloride (JP18/USP); Lariam (TN) |
(P) unclassified |
| D00836 |
Buprenorphine hydrochloride (JP18/USP); Buprenex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00840 |
Levomethadyl acetate hydrochloride (USAN); Orlaam (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00847 |
Oxycodone hydrochloride (USP); Oxecta (TN); Oxycontin (TN); Roxicodone (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00851 |
Erythromycin estolate (USP); Erythromycin estorate (JAN); Ilosone (TN) |
(P) unclassified |
| D00873 |
Lomefloxacin hydrochloride (JAN/USAN); Maxaquin (TN) |
(P) unclassified |
| D00874 |
Moxifloxacin hydrochloride (JAN/USP); Avelox (TN); Vigamox (TN) |
(P) unclassified |
| D00879 |
Rifapentine (USAN/INN); Priftin (TN) |
(P) CYP induction: CYP3A4 |
| D00880 |
Butoconazole nitrate (USP); Femstat (TN); Gynazole-1 (TN) |
(P) unclassified |
| D00881 |
Econazole nitrate (JAN/USP); Ecoza (TN); Spectazole (TN) |
(P) unclassified |
| D00882 |
Miconazole nitrate (JP18/USP); Micatin (TN); Monistat (TN) |
(P) unclassified |
| D00885 |
Oxiconazole nitrate (JAN/USAN); Oxistat (TN) |
(P) unclassified |
| D00886 |
Sulconazole nitrate (JAN/USP); Exelderm (TN) |
(P) unclassified |
| D00887 |
Atorvastatin calcium anhydorous; Lipitor (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00888 |
Terconazole (USP/INN); Terazol 3 (TN) |
(P) unclassified |
| D00889 |
Cerivastatin sodium (JAN/USAN); Baycol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00890 |
Tioconazole (JAN/USP/INN); Vagistat-1 (TN) |
(P) unclassified |
| D00892 |
Fluvastatin sodium (JAN/USP); Lescol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00894 |
Amprenavir (JAN/USAN/INN); Agenerase (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00896 |
Efavirenz (JAN/USP/INN); Sustiva (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00897 |
Indinavir sulfate (USP); Crixivan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00899 |
Nelfinavir mesylate (USAN/INN); Nelfinavir mesilate (JAN); Viracept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D00904 |
Diclofenac sodium (JP18/USP); Solaraze (TN); Voltaren (TN) |
(P) unclassified |
| D00944 |
Metformin hydrochloride (JP18/USP); Glucophage (TN) |
(P) unclassified |
| D00945 |
Pioglitazone hydrochloride (JP18/USP); Actos (TN) |
(P) unclassified |
| D00948 |
Estropipate (USP); Piperazine estrone sulfate; Ogen (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00951 |
Medroxyprogesterone acetate (JP18/USP); Depo-provera (TN); Depo-subq provera 104 (TN); Provera (TN) |
(CI,P) unclassified |
| D00961 |
Bicalutamide (JP18/USP/INN); Casodex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00963 |
Exemestane (JAN/USP/INN); Aromasin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00964 |
Letrozole (JAN/USP/INN); Femara (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00966 |
Tamoxifen citrate (JP18/USP); Nolvadex (TN); Soltamox (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00967 |
Toremifene citrate (JAN/USAN); Fareston (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00969 |
Meloxicam (JAN/USP/INN); Mobic (TN) |
(P) unclassified |
| D00971 |
Sodium thiosalicylate; Thiosalicylic acid sodium salt; Rexolate (TN) |
(P) unclassified |
| D00975 |
Dexamethasone sodium phosphate (JAN/USP); Dalalone (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D00979 |
Methylprednisolone acetate (JAN/USP); Depo-medrol (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D00987 |
Cabergoline (JP18/USP/INN); Cabaser (TN); Dostinex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01007 |
Propiverine hydrochloride (JP18); Bup-4 (TN); Mictonorm (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01028 |
Ticlopidine hydrochloride (JP18/USP); Ticlid (TN) |
(P) unclassified |
| D01029 |
Tirofiban hydrochloride (USAN); Tirofiban hydrochloride hydrate; Aggrastat (TN) |
(P) unclassified |
| D01061 |
Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP18); Irinotecan hydrochloride trihydrate; CPT 11; CPT-11; Campto (TN); Camptosar (TN); Onivyde (TN) |
(P) unclassified |
| D01068 |
Vinblastine sulfate (JP18/USP); Exal (TN); Velban (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01078 |
Telithromycin (JAN/USAN/INN); Ketek (TN) |
(P) unclassified |
| D01087 |
Methyl salicylate (JP18/NF); Methyl salicylate (TN) |
(P) unclassified |
| D01092 |
Lanoconazole (JP18/INN); Latoconazole; Astat (TN) |
(P) unclassified |
| D01098 |
Maxacalcitol (JAN/USAN/INN); Oxarol (TN); Prezios (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01101 |
Bromperidol (JAN/USAN/INN); Impromen (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01104 |
Barnidipine hydrochloride (JAN); Hypoca (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01111 |
Nateglinide (JP18/USP/INN); Starsis (TN) |
(P) unclassified |
| D01115 |
Eplerenone (JP18/USAN/INN); Inspra (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01121 |
Rebamipide (JP18/INN); Mucosta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01131 |
Lafutidine (JP18/INN); Protecadin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01144 |
Prulifloxacin (JAN/INN); Sword (TN) |
(P) unclassified |
| D01145 |
Azelnidipine (JP18/INN); Calblock (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01148 |
Tolterodine tartrate (JAN/USP); Detrol (TN); Detrusitol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01160 |
Saquinavir mesylate (USP); Saquinavir mesilate (JAN); Invirase (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01161 |
Fulvestrant (JAN/USP/INN); Faslodex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01163 |
Ergonovine maleate (USP); Ergometrine maleate (JP18); Ergometrine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01164 |
Aripiprazole (JAN/USP/INN); Abilify (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01173 |
Cilnidipine (JP18/INN); Atelec (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01176 |
Blonanserin (JAN/INN); AD 5423 |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01196 |
Acetazolamide sodium (JAN); Diamox (TN) |
(P) unclassified |
| D01207 |
Omeprazole sodium (USAN); Losec sodium (TN) |
(P) unclassified |
| D01213 |
Tolvaptan (JAN/USAN/INN); Samsca (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01217 |
Dydrogesterone (JP18/USP/INN); Duphaston (TN); Gynorest (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01220 |
Trapidil (JP18/INN); Rocornal (TN) |
(P) unclassified |
| D01227 |
Bosentan (USAN); Bosentan hydrate (JAN); Tracleer (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01235 |
Josamycin (JP18/USAN/INN); Leucomycin A3; JM; Josamycin (TN) |
(P) CYP inhibition: CYP3A4 |
| D01236 |
Conivaptan hydrochloride (JAN/USAN); Vaprisol (TN) |
(P) unclassified |
| D01240 |
Deslanoside (JP18/USP/INN); Cedilanid-d (TN) |
(P) unclassified |
| D01241 |
Penflutizide (JAN/INN) |
(P) unclassified |
| D01246 |
Benzylhydrochlorothiazide (JAN); Behyd (TN) |
(P) unclassified |
| D01247 |
Ethiazide (JAN/INN) |
(P) unclassified |
| D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01256 |
Cyclothiazide (JAN/USAN/INN); Anhydron (TN) |
(P) unclassified |
| D01263 |
Ritodrine hydrochloride (JP18/USP); Yutopar (TN) |
(P) unclassified |
| D01269 |
Solifenacin succinate (JAN/USAN/INN); Vesicare (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01276 |
Atazanavir sulfate (JAN/USAN); Reyataz (TN) |
(P) CYP inhibition: CYP3A4 |
| D01280 |
Warfarin potassium (JP18); Athrombin-K (TN) |
(P) unclassified |
| D01287 |
Levobupivacaine hydrochloride (JAN/USAN); Chirocaine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01293 |
Ethyl loflazepate (JP18/INN); Meilax (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01302 |
Hydralazine hydrochloride (JP18/USP); Apresoline (TN) |
(P) unclassified |
| D01316 |
Mexazolam (JAN/INN); Melex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01322 |
Troleandomycin (USAN/INN); Triacetyloleandomycin (JAN); TAO; Tao (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D01323 |
Azosemide (JP18/USAN/INN); Diart (TN) |
(P) unclassified |
| D01333 |
Urapidil (JP18/INN); Ebrantil (TN) |
(P) unclassified |
| D01337 |
Epoprostenol sodium (JAN/USAN); Flolan (TN); Veletri (TN) |
(P) unclassified |
| D01339 |
Midecamycin (JP18/INN); Medemycin (TN) |
(P) CYP inhibition: CYP3A4 |
| D01355 |
Tramadol hydrochloride (JP18/USP); Ultram (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01356 |
Glymidine sodium (JAN/USAN/INN) |
(P) unclassified |
| D01358 |
Mianserin hydrochloride (JAN/USAN); Tetramide (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01360 |
Clenbuterol hydrochloride (JAN/USP); Spiropent (TN) |
(P) unclassified |
| D01361 |
Erythromycin ethylsuccinate (JP18/USP); E.E.S. (TN); Eryped (TN); Erythrocin W (TN) |
(P) unclassified |
| D01362 |
Tulobuterol hydrochloride (JP18); Hokunalin (TN); Respacal (TN) |
(P) unclassified |
| D01372 |
Zopiclone (JP18/INN); Amoban (TN); Zopiclone (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01375 |
Methenolone acetate (USAN); Metenolone acetate (JP18); Primobolan (TN) |
(P) unclassified |
| D01386 |
Ephedrine hydrochloride (JP18/USP); Ephedrine hydrochloride (TN) |
(P) unclassified |
| D01390 |
Isoproterenol hydrochloride (USP); dl-Isoprenaline hydrochloride (JAN); Isuprel (TN); Proternol-S (TN) |
(P) unclassified |
| D01399 |
Fentanyl citrate (JP18/USP); Abstral (TN); Fentora (TN); Lazanda (TN); Oralet (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01413 |
Estradiol valerate (JAN/USP/INN); Deladumone (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01418 |
Tamibarotene (JAN/USAN/INN); Am 80; Amnoid (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01425 |
Lopinavir (JAN/USP/INN) |
(P) unclassified |
| D01428 |
Fenoterol hydrobromide (JAN); Berotec (TN) |
(P) unclassified |
| D01429 |
Fosfluconazole (JAN/INN); Prodif (TN) |
(P) CYP inhibition: CYP3A4 |
| D01436 |
Clorexolone (JAN/USAN/INN) |
(P) unclassified |
| D01441 |
Imatinib mesylate (USAN); Imatinib mesilate (JAN); Gleevec (TN); Glivec (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01450 |
Bupivacaine hydrochloride (USP); Bupivacaine hydrochloride hydrate (JP18); Marcaine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01453 |
Caffeine hydrate (JP18); Caffeine monohydrate; Caffeine (TN) |
(P) unclassified |
| D01455 |
Cifenline succinate (USAN); Cibenzoline succinate (JP18); Cibenol (TN); Cipralan (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01466 |
Ethenzamide (JP18/INN); Ethenzamide (TN) |
(P) unclassified |
| D01468 |
Nemonapride (JAN/INN); Emilace (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01475 |
Flurbiprofen axetil (JAN); FP 83; Ropion (TN) |
(P) unclassified |
| D01478 |
Ebastine (JP18/USAN/INN); Kestine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01480 |
Isoconazole nitrate (JAN); Adestan-G (TN) |
(P) unclassified |
| D01481 |
Dihydrocodeine phosphate (JP18); Dihydro (TN) |
(P) unclassified |
| D01510 |
Dexamethasone metasulfobenzoate sodium (JAN); Dexamethazone metasulfobenzoate sodium; Dexapos; Santeson (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D01514 |
Etizolam (JP18/INN); Sedekopan (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01551 |
Beraprost sodium (JP18/USAN); Procylin (TN) |
(P) unclassified |
| D01553 |
Manidipine hydrochloride (JP18); Manidipine dihydrochloride; Calslot (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01557 |
Glycol salicylate (JAN); Ethylene glycol salicylate; Norgesic (TN); Phlogont (TN) |
(P) unclassified |
| D01562 |
Aranidipine (JAN/INN); Sapresta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01564 |
Rilmazafone hydrochloride hydrate (JP18); Rilmazafone hydrochloride dihydrate; Rilmazafone hydrochloride; Rhythmy (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01599 |
Gliclazide (JP18/INN); Glimicron (TN) |
(P) unclassified |
| D01603 |
Bethanidine sulfate (JAN/USAN); Tenathan (TN) |
(P) unclassified |
| D01605 |
Meticrane (JP18/INN); Arresten (TN) |
(P) unclassified |
| D01614 |
Acetylkitasamycin (JP18); Neo-leucomycin H (TN) |
(P) unclassified |
| D01615 |
Dexamethasone palmitate (JAN); Dexamethasone 21-palmitate; Limethason (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D01617 |
Estradiol dipropionate (JAN); Ovahormon (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01620 |
Neticonazole hydrochloride (JAN); Atolant (TN) |
(P) unclassified |
| D01624 |
Sarpogrelate hydrochloride (JP18); Anplag (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01632 |
Dexamethasone dipropionate (USAN); Dexamethasone propionate (JAN); Hifmeta (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D01634 |
Piretanide (JAN/USAN/INN); Arelix (TN) |
(P) unclassified |
| D01636 |
Midecamycin acetate (JP18); Miocamycin; Miocamycin (TN) |
(P) CYP inhibition: CYP3A4 |
| D01663 |
Quinine ethylcarbonate (JP18); Quinine ethylcarbonate (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01664 |
Omoconazole nitrate (JAN/USAN) |
(P) unclassified |
| D01665 |
Voglibose (JP18/USAN/INN); Basen (TN) |
(P) unclassified |
| D01670 |
Nafamostat mesylate (USAN); Nafamostat mesilate (JP18); Ronastat (TN) |
(P) unclassified |
| D01672 |
Gabexate mesilate (JP18); Gabexate mesylate; Arodate (TN) |
(P) unclassified |
| D01683 |
Ozagrel hydrochloride hydrate (JAN); Ozagrel hydrochloride; Ozagrel (TN) |
(P) unclassified |
| D01684 |
Ozagrel sodium (JP18); Ozapen (TN) |
(P) unclassified |
| D01692 |
Alfuzosin hydrochloride (JAN/USAN); Uroxatral (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01699 |
Darifenacin hydrobromide (JAN/USAN); Enablex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01703 |
Ciclesonide (JAN/USAN/INN); Alvesco (TN); Omnaris (TN); Zetonna (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D01708 |
Fluticasone propionate (JAN/USP); Cutivate (TN); Flonase (TN); Flovent (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D01710 |
Roxithromycin (JP18/USAN/INN); Rulide (TN) |
(P) unclassified |
| D01744 |
Brotizolam (JP18/USAN/INN); Lendormin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01745 |
Domperidone (JP18/USAN/INN); Motilium (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01775 |
Bifonazole (JP18/USAN/INN); Mycospor (TN) |
(P) unclassified |
| D01799 |
Glyclopyramide (JAN/INN); Deamelin-S (TN) |
(P) unclassified |
| D01804 |
Cadralazine (JP18/INN); Cadral (TN) |
(P) unclassified |
| D01810 |
Nicorandil (JP18/USAN/INN); Sigmart (TN) |
(P) unclassified |
| D01811 |
Salicylamide (JAN/USP/INN); Salicylamide (TN) |
(P) unclassified |
| D01822 |
Clofenamide (JAN/INN) |
(P) unclassified |
| D01832 |
Modafinil (JAN/USP/INN); Provigil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01844 |
Fondaparinux sodium (JAN/USP/INN); Arixtra (TN) |
(P) unclassified |
| D01854 |
Mitiglinide calcium hydrate (JP18); Mitiglinide calcium dihydrate; Glufast (TN) |
(P) unclassified |
| D01855 |
Mozavaptane hydrochloride (JAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01872 |
Doxapram hydrochloride (USP); Doxapram hydrochloride hydrate (JP18); Dopram (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01877 |
Mefruside (JP18/USAN/INN); Baycaron (TN) |
(P) unclassified |
| D01892 |
Icosapent ethyl (USAN); Ethyl icosapentate (JP18); Epadel S (TN); Vascepa (TN) |
(P) unclassified |
| D01895 |
Tripamide (JAN/USAN/INN); Normonal (TN) |
(P) unclassified |
| D01896 |
Cilostazol (JP18/USP/INN); Pletal (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01897 |
Rokitamycin (JAN/INN); Ricamycin (TN) |
(P) unclassified |
| D01898 |
Haloperidol decanoate (JAN/USP); Halomonth (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01908 |
Nilvadipine (JP18/USAN/INN); Nivadil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01935 |
Vinorelbine tartrate (USP); Vinorelbine ditartrate (JAN); KW 2307; Navelbine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01943 |
Canrenoate potassium (USAN); Potassium canrenoate (JP18); Soldactone (TN) |
(P) unclassified |
| D01948 |
Dexamethasone valerate (JAN); Dexamethasone 17-valerate; DV-17; Voalla ointment (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D01953 |
Estradiol benzoate (JP18/USP); Ovahormon (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01965 |
Silodosin (JP18/INN); KMD 3213; Rapaflo (TN); Urief (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01973 |
Eletriptan hydrobromide (JAN/USAN); Relpax (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01977 |
Gefitinib (JP18/USAN/INN); Iressa (TN) |
(P) unclassified |
| D01980 |
Luliconazole (JAN/USAN/INN); Lulicon (TN); Luzu (TN) |
(P) CYP inhibition: CYP3A4 |
| D01981 |
Ximelagatran (JAN/USAN/INN); Exanta (TN) |
(P) unclassified |
| D01984 |
Esomeprazole magnesium (USP); Esomeprazole magnesium hydrate (JAN); Esomeprazole magnesium trihydrate; Nexium (TN) |
(P) unclassified |
| D01994 |
Mosapride citrate hydrate (JP18); Mosapride citrate dihydrate; Gasmotin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01996 |
Tosufloxacin tosylate hydrate (JP18); Tosufloxacin tosilate; Ozex (TN); Tosuxacin (TN) |
(P) unclassified |
| D02000 |
Kitasamycin tartrate (JP18); Leucomycin tartrate (TN) |
(P) unclassified |
| D02008 |
Tadalafil (JAN/USP/INN); Adcirca (TN); Cialis (TN); Zalutia (TN) |
(CI,P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02009 |
Erythromycin lactobionate (JP18/USP); Erythrocin (TN) |
(P) unclassified |
| D02045 |
Benidipine hydrochloride (JP18); KW 3049; Coniel (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02061 |
Cyclopenthiazide (JAN/USAN/INN); Navidrex (TN) |
(P) unclassified |
| D02086 |
Lidocaine hydrochloride (JAN/USP); Dalcaine (TN); Xylocaine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02096 |
Fosphenytoin sodium (USP); Cerebyx (TN); Sesquient (TN) |
(P) CYP induction: CYP3A4 |
| D02101 |
Codeine phosphate (USP); Codeine phosphate hydrate (JP18); Codeine (TN) |
(P) unclassified |
| D02102 |
Methadone hydrochloride (JAN/USP); Dolophine hydrochloride (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP18); Aleviatin (TN); Dilantin (TN) |
(P) unclassified |
| D02109 |
dl-Methylephedrine hydrochloride (JP18); Methy-F (TN) |
(P) unclassified |
| D02112 |
Heparin sodium (JP18/USP/INN); Parnaparin sodium (INN); Liquemin sodium (TN) |
(P) unclassified |
| D02114 |
Hydroxychloroquine sulfate (JAN/USP); Plaquenil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02134 |
Azithromycin hydrate (JP18); Azithromycin dihydrate; Zithromac (TN); Zmax (TN); Azimycin (TN) |
(P) unclassified |
| D02150 |
l-Isoprenaline hydrochloride (JP18); Proternol-L (TN) |
(P) unclassified |
| D02151 |
Tulobuterol (JP18/INN); Atenos (TN); Hokunalin (TN) |
(P) unclassified |
| D02165 |
Docetaxel (USP); Docetaxel hydrate (JP18); Docetaxel trihydrate; Taxotere (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02169 |
Croconazole hydrochloride (JP18); Pilzcin (TN) |
(P) unclassified |
| D02173 |
Galantamine hydrobromide (JAN/USP); Razadyne (TN); Reminyl (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02174 |
Dexamethasone acetate (JAN/USP); Decadronal (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D02175 |
Compound oxycodone (JP18); Pavinal (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02184 |
Erythromycin stearate (JP18/USP); Bristamycin (TN) |
(P) unclassified |
| D02186 |
Oleandomycin phosphate (JAN); Matromycin (TN) |
(P) unclassified |
| D02205 |
Ethylmorphine hydrochloride hydrate (JP18); Ethylmorphine hydrochloride dihydrate; Ethylmorphine hydrochloride (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02206 |
Buformin hydrochloride (JP18); Dibetos-B (TN) |
(P) unclassified |
| D02211 |
Dihydroergotamine mesylate (USP); Dihydroergotamine mesilate (JP18); Migranal (TN); Trudhesa (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02216 |
Ciprofloxacin hydrochloride (USP); Ciprofloxacin hydrochloride hydrate (JP18); Ciloxan (TN); Cipro (TN); Proquin XR (TN) |
(P) unclassified |
| D02219 |
Terbinafine hydrochloride (JP18/USP); Lamisil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02229 |
Sildenafil citrate (JAN/USP); Revatio (TN); Viagra (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02235 |
Desmopressin acetate (USP); Desmopressin acetate hydrate (JAN); Desmopressin acetate trihydrate; DDAVP (TN); Minirinmelt (TN); Stimate (TN) |
(CI) unclassified |
| D02237 |
Guanethidine sulfate (USAN) |
(P) unclassified |
| D02258 |
Atorvastatin calcium (USP); Atorvastatin calcium hydrate (JP18); Atorvastatin calcium trihydrate; Atorvaliq (TN); Lipitor (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02261 |
Quinine hydrochloride hydrate (JP18); Quinine hydrochloride dihydrate; Quinine hydrochloride (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02262 |
Quinine sulfate (USP); Quinine sulfate hydrate (JP18); Quinine hydrogen sulfate; Coco-quinine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02268 |
Ergoloid mesylates (USP); Dihydroergotoxine mesilate (JP18); Circanol (TN); Hydergine (TN); Inorter (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02269 |
Kitasamycin (JP18/USAN); Leucomycin (TN) |
(P) unclassified |
| D02323 |
Tolrestat (USAN/INN); Alredase (TN) |
(P) unclassified |
| D02340 |
Loxapine (USAN/INN); Adasuve (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02356 |
Verapamil (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D02360 |
Sertraline (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02363 |
Ketanserin (USAN/INN) |
(P) unclassified |
| D02372 |
Perospirone hydrochloride hydrate (JAN); Lullan (TN) |
(P) unclassified |
| D02375 |
Terbinafine (USAN/INN); Lamasil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02386 |
Ticrynafen (USAN); Tienilic acid (INN); Selacryn (TN) |
(P) unclassified |
| D02404 |
Procaterol hydrochloride (USAN); Pro-Air (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02420 |
Acetylspiramycin (JP18); Spiramycin II; Acetylspiramycin (TN) |
(P) unclassified |
| D02425 |
Carbutamide (INN); Invenol (TN) |
(P) unclassified |
| D02426 |
Glycyclamide (INN); Tolcyclamide |
(P) unclassified |
| D02427 |
Glibornuride (USAN/INN); Glutril (TN) |
(P) unclassified |
| D02428 |
Glisentide (INN); Glypentide; Staticum (TN) |
(P) unclassified |
| D02429 |
Glisolamide (INN); Glysolamide; Diabenor (TN) |
(P) unclassified |
| D02430 |
Gliquidone (INN); Glurenorm (TN) |
(P) unclassified |
| D02453 |
Flumethiazide (INN); Ademol (TN) |
(P) unclassified |
| D02460 |
Clopamide (USAN/INN); Aquex (TN) |
(P) unclassified |
| D02475 |
Sitafloxacin (USAN); Sitafloxacin hydrate (JAN) |
(P) unclassified |
| D02478 |
Disulfamide (BAN) |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
| D02490 |
Tylosin (USP/INN); TS; Tylan (TN) |
(P) unclassified |
| D02492 |
Tilmicosin (USP/INN); TMS; Micotil (TN) |
(P) unclassified |
| D02493 |
Tilmicosin phosphate (USAN); TP |
(P) unclassified |
| D02497 |
Fosamprenavir (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D02498 |
Lopinavir and ritonavir; Kaletra (TN) |
(P) unclassified |
| D02501 |
Caspofungin acetate (JAN/USAN); Cancidas (TN) |
(P) unclassified |
| D02523 |
Erythromycin acistrate (USAN); Erasis (TN) |
(P) unclassified |
| D02524 |
Erythromycin gluceptate (USP); Erythromycin glucoheptonate; Ilotycin gluceptate (TN) |
(P) unclassified |
| D02525 |
Erythromycin propionate (USAN) |
(P) unclassified |
| D02540 |
Garenoxacin mesylate (USAN); Garenoxacin mesilate hydrate (JAN) |
(P) unclassified |
| D02554 |
Rifaximin (JAN/USAN/INN); Xifaxan (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02555 |
Posaconazole (JAN/USAN/INN); Noxafil (TN) |
(P) CYP inhibition: CYP3A4 |
| D02556 |
Ravuconazole (prop.INN) |
(P) unclassified |
| D02557 |
Chlormidazole (INN) |
(P) unclassified |
| D02564 |
Pargyline hydrochloride (USAN); Eutonyl (TN) |
(P) unclassified |
| D02567 |
Escitalopram oxalate (JAN/USP); Lexapro (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02570 |
Desvenlafaxine succinate (USAN); Desvenlafaxine succinate hydrate (JAN); Desvenlafaxine succinate monohydrate; Pristiq (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02577 |
Flibanserin (USAN/INN); Addyi (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02582 |
Fenticonazole (INN) |
(P) unclassified |
| D02583 |
Fenticonazole nitrate (USAN); Lomexin (TN) |
(P) unclassified |
| D02584 |
Aliconazole (INN) |
(P) unclassified |
| D02585 |
Vibunazole; Bay N-7133 |
(P) unclassified |
| D02586 |
Alteconazole (INN) |
(P) unclassified |
| D02587 |
Metildigoxin (JP18); Lanirapid (TN) |
(P) unclassified |
| D02591 |
Dexamethasone acefurate (USAN/INN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D02592 |
Dexamethasone beloxil (USAN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D02593 |
Pantoprazole sodium (USP); Pantoprazole sodium hydrate (JAN); Protonix (TN) |
(P) unclassified |
| D02624 |
Eszopiclone (JAN/USP/INN); Estorra (TN); Lunesta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02626 |
Bromperidol decanoate (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02666 |
Iloperidone (USAN/INN); Fanapt (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02690 |
Cholestyramine resin (USP); Colestyramine (JAN/INN); Questran (TN) |
(P) unclassified |
| D02691 |
Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) |
(P) unclassified |
| D02714 |
Everolimus (JAN/USAN/INN); Afinitor (TN); Votubia (TN); Zortress (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02715 |
Balsalazide disodium (USP); Colazide (TN) |
(P) unclassified |
| D02720 |
Beraprost (USAN) |
(P) unclassified |
| D02721 |
Iloprost (USAN/INN); Ventavis (TN) |
(P) unclassified |
| D02722 |
Limaprost (INN) |
(P) unclassified |
| D02731 |
Vardenafil dihydrochoride (USAN); Levitra (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02732 |
Pranlukast hydrate (JP18); Onon (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02740 |
Lidocaine and prilocaine; Lidocaine and propitocaine; Emla (TN); Oraqix (TN); Lidocaine and prilocaine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02749 |
Teceleukin (USAN); Teceleukin (genetical recombination) (JP18); Imunace (TN) |
(P) unclassified |
| D02778 |
Abciximab (USAN/INN); Abciximab (genetical recombination) (JAN); Reopro (TN) |
(P) unclassified |
| D02824 |
Almotriptan (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02825 |
Almotriptan malate (USP); Axert (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02829 |
Alosetron hydrochloride (USAN); Lotrpnex (TN) |
(P) unclassified |
| D02837 |
Alteplase (USP/INN); Alteplase (genetical recombination) (JAN); Activase (TN); Cathflo activase (TN) |
(P) unclassified |
| D02838 |
Althiazide (USAN); Altizide (INN) |
(P) unclassified |
| D02860 |
Limaprost alfadex (JP18); Opalmon (TN) |
(P) unclassified |
| D02861 |
Indinavir sulfate ethanolate (JAN); Crixivan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D02867 |
Fosamprenavir calcium hydrate (JAN); Lexiva (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D02910 |
Amiodarone (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02914 |
Amlodipine maleate (USAN); Amvaz (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02938 |
Ancrod (USAN/INN); Viprinex (TN) |
(P) unclassified |
| D02947 |
Anistreplase (USAN/INN); Eminase (TN) |
(P) unclassified |
| D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D02980 |
Adomiparin sodium (USAN); Ardeparin sodium (USAN/INN); Semuloparin sodium (USAN/INN); Normiflo (TN) |
(P) unclassified |
| D02994 |
Rituximab (USAN/INN); Rituximab (genetical recombination) (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 2] (JAN); Rituximab-abbs; Rituximab-pvvr; Rituximab-arrx; Rituxan (TN); Riabni (TN); Truximab (TN) |
(P) unclassified |
| D03023 |
Azaconazole (USAN/INN) |
(P) unclassified |
| D03063 |
BCG vaccine (USP); Freeze-dried BCG vaccine (for percutaneous use) (JP18); BCG vaccine (TN) |
(CI) unclassified |
| D03098 |
Berythromycin (USAN/INN); Erythromycin B |
(P) unclassified |
| D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(P) unclassified |
| D03136 |
Bivalirudin (USAN/INN) |
(P) unclassified |
| D03150 |
Bortezomib (JAN/USAN/INN); Velcade (TN) |
(P) unclassified |
| D03157 |
Brinolase (USAN); Brinase (INN) |
(P) unclassified |
| D03164 |
Bromindione (USAN/INN) |
(P) unclassified |
| D03165 |
Bromocriptine (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D03189 |
Buthiazide (USAN); Butizide (INN) |
(P) unclassified |
| D03208 |
Aliskiren (USAN/INN); Rasilez (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03213 |
Apixaban (JAN/USAN/INN); Eliquis (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03215 |
Armodafinil (USAN/INN); Nuvigil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03217 |
Avanafil (USAN/INN); Stendra (TN); Spedra (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03218 |
Axitinib (JAN/USAN); Inlyta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03230 |
Insulin human (USP/INN); Insulin human (genetical recombination) (JP18); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN); Humulin (TN) |
(P) unclassified |
| D03250 |
Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP18); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN); Lantus (TN) |
(P) unclassified |
| D03252 |
Bosutinib (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03253 |
Brecanavir (USAN) |
(P) unclassified |
| D03259 |
Gemtuzumab ozogamicin (USAN); Gemtuzumab ozogamicin (genetical recombination) (JAN); Gemtuzumab (INN); Mylotarg (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03260 |
Vardenafil hydrochloride hydrate (JAN); Vardenafil monohydrochloride trihydrate; Levitra (TN); Staxyn (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03278 |
Enviomycin sulfate (JP18); Tuberactin (TN) |
(P) unclassified |
| D03297 |
Mecasermin (USAN/INN); Mecasermin (genetical recombination) (JAN); Increlex (TN); Myotrophin (TN) |
(P) unclassified |
| D03324 |
Nasaruplase (cell culture) (JAN); Prourokinase (plasminogen activator prolyse) |
(P) unclassified |
| D03325 |
Mometasone furoate hydrate (JAN); Mometasone furoate monohydrate; Nasonex (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D03337 |
Reviparin sodium (JAN); Clivarine (TN) |
(P) unclassified |
| D03341 |
Urokinase (JP18/USAN/INN); Abbokinase (TN) |
(P) unclassified |
| D03342 |
Camiglibose (USAN) |
(P) unclassified |
| D03352 |
Batroxobin (JAN/INN); Defibrase (TN) |
(P) unclassified |
| D03353 |
Dalteparin sodium (JAN/USP/INN); Ardeparin sodium; Fragmin (TN) |
(P) unclassified |
| D03359 |
Cangrelor (USAN/INN) |
(P) unclassified |
| D03361 |
Cangrelor tetrasodium (USAN); Kengreal (TN) |
(P) unclassified |
| D03363 |
Canrenone (USAN) |
(P) unclassified |
| D03385 |
Carbaspirin calcium (USAN); Carbasalate calcium (INN) |
(P) unclassified |
| D03415 |
Carvedilol phosphate (USAN); Carvedilol phosphate hydrate (JAN); Coreg CR (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03471 |
Chlorothiazide sodium (USP); Diuril (TN) |
(P) unclassified |
| D03492 |
Cifenline (USAN); Cibenzoline (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03493 |
Ciglitazone (USAN/INN) |
(P) unclassified |
| D03504 |
Cinacalcet (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03505 |
Cinacalcet hydrochloride (JAN/USAN); Sensipar (TN); Mimpara (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03526 |
Cisconazole (USAN/INN) |
(P) unclassified |
| D03579 |
Codeine polistirex (USAN) |
(P) unclassified |
| D03580 |
Codeine sulfate (USP); Codeine sulfate trihydrate; Codeine sulfate (TN) |
(P) unclassified |
| D03644 |
Danaparoid sodium (JAN/USAN); Orgaran (TN) |
(P) unclassified |
| D03653 |
Darglitazone sodium (USAN) |
(P) unclassified |
| D03654 |
Darifenacin (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03656 |
Darunavir (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D03658 |
Dasatinib (JAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03661 |
Dazmegrel (USAN/INN) |
(P) unclassified |
| D03663 |
Dazoxiben hydrochloride (USAN) |
(P) unclassified |
| D03664 |
Debrisoquin sulfate (USAN); Declinax (TN) |
(P) unclassified |
| D03669 |
Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) |
(P) CYP induction: CYP3A4 |
| D03671 |
Deflazacort (USAN/INN); Emflaza (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D03673 |
Deligoparin sodium (USAN/INN) |
(P) unclassified |
| D03674 |
Enoxaparin sodium (JAN/USP/INN); Lovenox (TN) |
(P) unclassified |
| D03692 |
Desirudin (USAN/INN); Iprivask (TN) |
(P) unclassified |
| D03695 |
Desmoteplase (USAN/INN) |
(P) unclassified |
| D03722 |
Efegatran sulfate (USAN) |
(P) unclassified |
| D03725 |
Hydrocodone bitartrate (USP); Hydrocodone bitartrate hemipentahydrate; Dicodid (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03728 |
Napsagatran (USAN) |
(P) unclassified |
| D03731 |
Selegiline (USAN/INN); Emsam (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03783 |
Oxycodone terephthalate (USP) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03798 |
Dicumarol (USAN); Dicoumarol (INN); Dicumarol (TN) |
(P) unclassified |
| D03799 |
Dienogest (JAN/USAN/INN); Endometrion (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03820 |
Dutasteride (JAN/USP/INN); Avodart (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03825 |
Dihydrocodeine bitartrate (USP) |
(P) unclassified |
| D03830 |
Diltiazem malate (USAN); Tiamate (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03833 |
Indinavir (USAN); Indinavir hydrate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D03835 |
Fosamprenavir calcium (USAN); Lexiva (TN); Telzir (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D03837 |
Fosamprenavir sodium (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D03839 |
Droxinavir hydrochloride (USAN) |
(P) unclassified |
| D03840 |
Palinavir (USAN/INN) |
(P) unclassified |
| D03842 |
Telinavir (USAN/INN) |
(P) unclassified |
| D03843 |
Tipranavir disodium (USAN) |
(P) unclassified |
| D03852 |
Droperidol and fentanyl citrate; Innovar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03865 |
Dirithromycin (USP/INN); Dynabac (TN) |
(P) unclassified |
| D03883 |
Doconazole (USAN/INN) |
(P) unclassified |
| D03917 |
Drospirenone (JAN/USP/INN); Slynd (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D03918 |
Drotrecogin alfa (activated) (USAN); Drotrecogin alfa; Xigris (TN) |
(P) unclassified |
| D03936 |
Econazole (USAN/INN) |
(P) unclassified |
| D03941 |
Edaglitazone sodium (USAN) |
(P) unclassified |
| D03960 |
Aspirin and dialuminate; Aspirin, aluminum glycinate and magnesium carbonate; Bufferin (TN) |
(P) unclassified |
| D03994 |
Endralazine mesylate (USAN); Endralazine monomethanesulfonate; Migranal (TN) |
(P) unclassified |
| D03996 |
Englitazone sodium (USAN) |
(P) unclassified |
| D03997 |
Enilconazole (USAN/INN) |
(P) unclassified |
| D04018 |
Ephedrine sulfate (USP); Akovaz (TN); Corphedra (TN); Emerphed (TN) |
(P) unclassified |
| D04023 |
Erlotinib hydrochloride (JAN/USAN); Tarceva (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04029 |
Razaxaban hydrochloride (USAN) |
(P) unclassified |
| D04033 |
Epithiazide (USAN); Epitizide (INN) |
(P) unclassified |
| D04048 |
Ropivacaine hydrochloride (USP); Ropivacaine hydrochloride hydrate (JAN); Anapeine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04052 |
Epinephrine and lidocaine hydrochloride; Adrenaline and lidocaine hydrochloride; Xylocaine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04054 |
Erythromycin salnacedin (USAN); Erythromycin salnacedin dihydrate |
(P) unclassified |
| D04056 |
Esomeprazole sodium (USAN); Nexium IV (TN) |
(P) unclassified |
| D04061 |
Estradiol acetate (USAN); Femring (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04063 |
Estradiol cypionate (USP); Depo-estradiol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04064 |
Estradiol enanthate (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04065 |
Estradiol undecylate (USAN/INN); Delestrec (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04070 |
Estrogens, conjugated (JAN/USP); Conjugated estrogens; Premarin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04079 |
Ethacrynate sodium (USP) |
(P) unclassified |
| D04103 |
Etoformin hydrochloride (USAN) |
(P) unclassified |
| D04111 |
Etozolin (USAN/INN) |
(P) unclassified |
| D04112 |
Etravirine (JAN/USAN/INN); Intelence (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04121 |
Exenatide (JAN/USAN/INN); Byetta (TN) |
(P) unclassified |
| D04145 |
Fendosal (USAN/INN); Alnovin (TN) |
(P) unclassified |
| D04148 |
Fenfluramine hydrochloride (JAN/USAN); Fintepla (TN); Pondimin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04161 |
Fenquizone (USAN/INN) |
(P) unclassified |
| D04183 |
Fidexaban (USAN/INN) |
(P) unclassified |
| D04206 |
Flufenisal (USAN/INN) |
(P) unclassified |
| D04214 |
Flunisolide acetate (USAN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D04265 |
Reserpine, hydralazine hydrochloride and hydrochlorothiazide |
(P) unclassified |
| D04266 |
Benzylhydrochlorothiazide, Reserpine and Carbazochrome; Behyd RA (TN) |
(P) unclassified |
| D04276 |
Furegrelate sodium (USAN) |
(P) unclassified |
| D04292 |
Galantamine (USAN/INN); Reminyl (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04300 |
Ganaxolone (USAN/INN); Ztalmy (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04313 |
Dihydrocodeine phosphate, dl-methylephedrine hydrochloride and Chlorpheniramine maleate; Huscode (TN) |
(P) unclassified |
| D04314 |
Gepirone hydrochloride (USAN); Exxua (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04318 |
Glatiramer acetate (JAN/USAN); Copaxone (TN) |
(P) unclassified |
| D04322 |
Gliamilide (USAN/INN) |
(P) unclassified |
| D04338 |
Dihydrocodeine phosphate, ephedrine hydrochloride and ammmonium chloride; Sekicode (TN) |
(P) unclassified |
| D04340 |
Dextromethorphan hydrobromide and potassium cresolsulfonate; Medicon (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04354 |
Glyhexamide (USAN/INN); Subose (TN) |
(P) unclassified |
| D04355 |
Glyoctamide (USAN/INN) |
(P) unclassified |
| D04356 |
Glyparamide (USAN) |
(P) unclassified |
| D04370 |
Granisetron (JAN/USAN/INN); Sancuso (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04382 |
Guanethidine monosulfate (USP); Guanethidine sulfate (JP18); Ismelin (TN) |
(P) unclassified |
| D04386 |
Guanoclor sulfate (USAN); Vatensol (TN) |
(P) unclassified |
| D04398 |
Guanoxabenz (USAN/INN) |
(P) unclassified |
| D04399 |
Guanoxan sulfate (USAN); Envacar (TN) |
(P) unclassified |
| D04403 |
Guar gum (NF) |
(P) unclassified |
| D04427 |
Heparin calcium (JP18); Nadroparin calcium (INN); Calciparin; Calciparine (TN) |
(P) unclassified |
| D04446 |
Betamethasone acetate and betamethasone sodium phosphate; Celestone soluspan (TN); Rinderon (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04447 |
Betamethasone and d-chlorpheniramine maleate; Celestamine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04458 |
Hydralazine polistirex (USAN) |
(P) unclassified |
| D04461 |
Hydrocodone polistirex (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04463 |
Norgestrel and ethinylestradiol tablets (JP18); Low-ogestrel (TN); Planovar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04475 |
Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP18); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN); Insulin X 14; NovoRapid (TN); Novolog (TN) |
(P) unclassified |
| D04477 |
Insulin lispro (USP/INN); Insulin lispro (genetical recombination) (JAN); Insulin lispro (genetical recombination) [Insulin lispro Biosimilar 1] (JAN); Insulin lispro-aabc; Humalog (TN); Lyumjev (TN) |
(P) unclassified |
| D04482 |
Ethinylestradiol and levonorgestrel; Ange (TN); Levora (TN); Lo/ovral (TN); Seasonique (TN); Triphasil-21 (TN); Trivora (TN) |
(P) unclassified |
| D04483 |
Ethinylestradiol and norethisterone; Norethindrone and ethinyl estradiol; Synphase T28 (TN) |
(P) unclassified |
| D04484 |
Desogestrel and ethinylestradiol; Marvelon21 (TN); Ortho-cept (TN) |
(P) unclassified |
| D04520 |
Indacrinone (USAN/INN) |
(P) unclassified |
| D04531 |
Indoramin (USAN/INN) |
(P) unclassified |
| D04532 |
Indoramin hydrochloride (USAN) |
(P) unclassified |
| D04539 |
Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN); Levemir (TN) |
(P) unclassified |
| D04540 |
Insulin glulisine (USAN/INN); Insulin glulisine (genetical recombination) (JAN); Apidra (TN) |
(P) unclassified |
| D04541 |
Insulin human, isophane (USP) |
(P) unclassified |
| D04542 |
Insulin human zinc (USP) |
(P) unclassified |
| D04543 |
Insulin human zinc, extended (USP) |
(P) unclassified |
| D04547 |
Insulin, isophane (USP); Isophane insulin human (genetical recombination) injectable aqueous suspension (JP18); Isophane insulin (aqueous suspension) (JAN); Humalog PEN (TN) |
(P) unclassified |
| D04548 |
Insulin, neutral (USAN); Neutral insulin injection (INN) |
(P) unclassified |
| D04550 |
Insulin zinc, prompt (USP); Semilente iletin (TN) |
(P) unclassified |
| D04551 |
Insulin zinc (USP); Lente iletin (TN) |
(P) unclassified |
| D04624 |
Isoconazole (USAN/INN) |
(P) unclassified |
| D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D04645 |
Ixabepilone (JAN/USAN/INN); Ixempra (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04665 |
Lanoteplase (USAN/INN); Lanoteplase (genetical recombination) (JAN) |
(P) unclassified |
| D04666 |
Lanreotide acetate (JAN/USAN); Somatuline (TN) |
(P) unclassified |
| D04716 |
Levomethadyl acetate (USAN); Levacetylmethadol (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04725 |
Lexithromycin (USAN/INN) |
(P) unclassified |
| D04752 |
Lixivaptan (USAN/INN) |
(P) unclassified |
| D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(P) unclassified |
| D04799 |
Heparinoid (JAN); Hirudoid (TN) |
(P) unclassified |
| D04813 |
Lidocaine hydrochloride and epinephrine bitartrate; Lidocaine hydrochloride and adrenaline bitartrate; Ora (TN); Lidosite (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04820 |
Lurasidone hydrochloride (JAN/USAN); SM 13496; Latuda (TN) |
(CI,P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04859 |
Maribavir (JAN/USAN/INN); Camvia (TN); Livtencity (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D04866 |
Freeze-dried live attenuated measles vaccine (JP18) |
(CI) unclassified |
| D04895 |
Mefloquine (USAN/INN) |
(P) unclassified |
| D04896 |
Megalomicin potassium phosphate (USAN) |
(P) unclassified |
| D04966 |
Metformin (USAN/INN) |
(P) unclassified |
| D04970 |
Methacholine chloride (JAN/USP/INN); Provocholine (TN) |
(P) unclassified |
| D04976 |
Methalthiazide (USAN) |
(P) unclassified |
| D04977 |
Parnaparin sodium (JP18); Lowhepa (TN) |
(P) unclassified |
| D05000 |
Methylprednisolone hemisuccinate (USP); Methylprednisolone succinate (JP18) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D05001 |
Methylprednisolone sodium phosphate (USAN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D05002 |
Methylprednisolone suleptanate (USAN/INN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D05028 |
Midazolam maleate (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D05029 |
Midostaurin (JAN/USAN/INN); Rydapt (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D05037 |
Trimetoquinol hydrochloride hydrate (JP18); Tretoquinol hydrate; Caluyon (TN) |
(P) unclassified |
| D05087 |
Moxonidine (USAN/INN); Cynt (TN) |
(P) unclassified |
| D05089 |
Freeze-dried live attenuated mumps vaccine (JP18); Freeze-dried live attenuated mumps vaccine (TN) |
(CI) unclassified |
| D05093 |
Muzolimine (USAN/INN) |
(P) unclassified |
| D05123 |
Nasaruplase beta (USAN/INN); Prolyse (TN) |
(P) unclassified |
| D05150 |
Netoglitazone (USAN/INN) |
(P) unclassified |
| D05153 |
Neutramycin (USAN) |
(P) unclassified |
| D05181 |
Aspirin aluminum (JP18) |
(P) unclassified |
| D05248 |
Freeze-dried inactivated tissue culture ravies vaccine (JP18) |
(P) unclassified |
| D05259 |
Omeprazole magnesium (USP); Prilosec OTC (TN) |
(P) unclassified |
| D05261 |
Omeprazole sodium injection (JAN); Omeprazole sodium hydrate; Omepral (TN) |
(P) unclassified |
| D05268 |
Orconazole nitrate (USAN) |
(P) unclassified |
| D05277 |
Formoterol fumarate hydrate (JP18); Formoterol fumarate dihydrate; Atock (TN); Foradil (TN) |
(P) unclassified |
| D05312 |
Oxycodone (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D05323 |
Ozolinone (USAN) |
(P) unclassified |
| D05333 |
Paclitaxel poliglumex (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D05343 |
Palonosetron hydrochloride (JAN/USP); Aloxi (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D05351 |
Josamycin propionate (JP18); Josamy (TN) |
(P) CYP inhibition: CYP3A4 |
| D05353 |
Pantoprazole (USAN/INN) |
(P) unclassified |
| D05366 |
Procaterol hydrochloride hydrate (JP18); Meptin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D05367 |
Parconazole hydrochloride (USAN) |
(P) unclassified |
| D05380 |
Pazopanib hydrochloride (JAN/USAN); Votrient (TN) |
(P) unclassified |
| D05382 |
Pazufloxacin mesilate (JP18); Pazufloxacin methanesulfonate; Pasil (TN) |
(P) unclassified |
| D05387 |
Pegaspargase (JAN/USAN/INN); Oncaspar (TN) |
(P) unclassified |
| D05410 |
Pamiteplase (INN); Pamiteplase (genetical recombination) (JAN); Solinase (TN) |
(P) unclassified |
| D05412 |
Monteplase (INN); Monteplase (genetical recombination) (JAN); Cleactor (TN) |
(P) unclassified |
| D05457 |
Phenprocoumon (USAN/INN); Liquamar (TN) |
(P) unclassified |
| D05462 |
Oxycodone hydrochloride hydrate (JP18) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D05482 |
Pinacidil (USAN); Pinacidil hydrate; Pindac (TN) |
(P) unclassified |
| D05502 |
Pirmagrel (USAN/INN); CGS 13080 |
(P) unclassified |
| D05538 |
Mozenavir (INN) |
(P) unclassified |
| D05594 |
Pramlintide (USAN/INN) |
(P) unclassified |
| D05595 |
Pramlintide acetate (USAN); Symlin (TN) |
(P) unclassified |
| D05597 |
Prasugrel hydrochloride (JAN/USAN); Effient (TN) |
(P) unclassified |
| D05622 |
Proinsulin human (USAN) |
(P) unclassified |
| D05640 |
Prorenoate potassium (USAN/INN) |
(P) unclassified |
| D05681 |
Quinine ascorbate (USAN); Quinine biascorbate |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D05705 |
Rauwolfia serpentina (USP); Rauwolfia extract; Himolfia (TN) |
(P) unclassified |
| D05713 |
Relomycin (USAN/INN) |
(P) unclassified |
| D05717 |
Repromicin (USAN/INN) |
(P) unclassified |
| D05721 |
Reteplase (USAN/INN); Retevase (TN) |
(P) unclassified |
| D05727 |
Ridogrel (USAN/INN) |
(P) unclassified |
| D05739 |
Rivoglitazone (USAN/INN) |
(P) unclassified |
| D05744 |
Roflumilast (JAN/USAN/INN); Daliresp (TN); Zoryve (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D05757 |
Rosaramicin (USAN/INN) |
(P) unclassified |
| D05758 |
Rosaramicin butyrate (USAN) |
(P) unclassified |
| D05759 |
Rosaramicin propionate (USAN) |
(P) unclassified |
| D05760 |
Rosaramicin sodium phosphate (USAN) |
(P) unclassified |
| D05761 |
Rosaramicin stearate (USAN) |
(P) unclassified |
| D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) unclassified |
| D05788 |
Salcolex (USAN); Salcolex tetrahydrate |
(P) unclassified |
| D05789 |
Salethamide maleate (USAN) |
(P) unclassified |
| D05791 |
Salicylate meglumine (USAN) |
(P) unclassified |
| D05792 |
Salmeterol (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D05793 |
Salnacedin (USAN/INN) |
(P) unclassified |
| D05800 |
Saperconazole (USAN/INN) |
(P) unclassified |
| D05811 |
Sedecamycin (USAN/INN) |
(P) unclassified |
| D05908 |
Spiramycin (JAN/USAN/INN); Rovamycin (TN) |
(P) unclassified |
| D05912 |
Spiroxasone (USAN/INN) |
(P) unclassified |
| D05928 |
Stiripentol (JAN/USAN/INN); Diacomit (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D05932 |
Streptozocin (JAN/USAN/INN); Streptozotocin; Zanosar (TN) |
(P) unclassified |
| D05987 |
Synthetic conjugated estrogens, B (USAN); Enjuvia (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D05998 |
Talosalate (USAN/INN) |
(P) unclassified |
| D06068 |
Temsirolimus (JAN/USAN/INN); Torisel (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06070 |
Tenecteplase (USAN/INN); Tnkase (TN) |
(P) unclassified |
| D06142 |
Tifacogin (USAN/INN) |
(P) unclassified |
| D06177 |
Tolbutamide sodium, sterile; Orinase diagnostic (TN) |
(P) unclassified |
| D06186 |
Tolpyrramide (USAN/INN) |
(P) unclassified |
| D06199 |
Trabectedin (JAN/USAN/INN); Yondelis (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06213 |
Treprostinil (JAN/USAN/INN); Remodulin (TN) |
(P) unclassified |
| D06234 |
Trimazosin hydrochloride (USAN); Trimazosin hydrochloride monohydrate |
(P) unclassified |
| D06256 |
Tuberculin (USP); Purified tuberculin; Aplisol (TN) |
(P) unclassified |
| D06258 |
Tulathromycin (JAN/USAN/INN) |
(P) unclassified |
| D06270 |
Urokinase alfa (USAN/INN); r-UK (TN) |
(P) unclassified |
| D06272 |
Sorafenib tosylate (USAN); Sorafenib tosilate (JAN); Nexavar (TN) |
(P) unclassified |
| D06273 |
Imidafenacin (JAN/INN); Uritos (TN); Staybla (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06315 |
Fluticasone furoate (JAN/USAN/INN); Veramyst (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D06341 |
Xipamide (USAN) |
(P) unclassified |
| D06347 |
Yellow fever vaccine (USP); YF-Vax (TN) |
(CI) unclassified |
| D06373 |
Zinoconazole hydrochloride (USAN) |
(P) unclassified |
| D06390 |
Azithromycin (USP); Zmax (TN) |
(P) unclassified |
| D06398 |
Tinzaparin sodium (USAN); Innohep (TN) |
(P) unclassified |
| D06401 |
Indapamide hydrate; Tenaxil (TN) |
(P) unclassified |
| D06402 |
Sunitinib malate (JAN/USAN); Sutent (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06404 |
Liraglutide (USAN/INN); Liraglutide (genetical recombination) (JAN); Victoza (TN) |
(P) unclassified |
| D06405 |
Nalfurafine hydrochloride (JAN/USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06407 |
Vandetanib (JAN/USAN/INN); Caprelsa (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06410 |
Thrombomodulin alfa (USAN/INN); Thrombomodulin alfa (genetical recombination) (JAN) |
(P) unclassified |
| D06412 |
Aliskiren fumarate (JAN/USAN); Aliskiren hemifumarate; Tekturna (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06466 |
Freeze-dried BCG for intravesical use; Immunobladder (TN); Tice BCG (TN) |
(CI) unclassified |
| D06478 |
Darunavir ethanolate (JAN); Prezista (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D06511 |
Freeze-dried smallpox vaccine prepared in cell culture (JP18) |
(CI) unclassified |
| D06512 |
Freeze-dried live attenuated rubella vaccine (JP18) |
(CI) unclassified |
| D06553 |
Alogliptin benzoate (JAN/USAN); Vipidia (TN); Nesina (TN) |
(P) unclassified |
| D06571 |
Antithrombin III human (USP); Antithrombin III (INN); Kybernin (TN) |
(P) unclassified |
| D06578 |
Denagliptin tosylate (USAN) |
(P) unclassified |
| D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D06598 |
Gamithromycin (USAN/INN) |
(P) unclassified |
| D06606 |
Ibuprofen lysine (USAN); Ibuprofen L-lysine (JAN); Solufenum; Neoprofen (TN) |
(P) unclassified |
| D06630 |
Pramiconazole (USAN/INN) |
(P) unclassified |
| D06641 |
Sergliflozin etabonate (USAN) |
(P) unclassified |
| D06645 |
Sitagliptin phosphate (USAN); Sitagliptin phosphate hydrate (JP18); Sitagliptin phosphate monohydrate; Januvia (TN) |
(P) unclassified |
| D06670 |
Maraviroc (JAN/INN); Selzentry (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D06879 |
Streptokinase (INN); Streptase (TN) |
(P) unclassified |
| D06880 |
Lepirudin (INN); Refludan (TN) |
(P) unclassified |
| D06883 |
Sertaconazole (INN) |
(P) unclassified |
| D06888 |
Eptifibatide (INN); Integrilin (TN) |
(P) unclassified |
| D07064 |
Acenocoumarol (INN); Acenocoumarin; Mini-sintrom (TN) |
(P) unclassified |
| D07073 |
Dexamethasone cipecilate (JAN/INN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D07077 |
Ambrisentan (JAN/INN); Letairis (TN); Volibris (TN) |
(P) unclassified |
| D07080 |
Vildagliptin (JAN/USAN/INN); Equa (TN); Galvus (TN) |
(P) unclassified |
| D07082 |
Dabigatran etexilate mesylate (USAN); Dabigatran etexilate methanesulfonate (JAN); Dabigatran etexilate mesilate; Pradaxa (TN) |
(P) unclassified |
| D07086 |
Rivaroxaban (JAN/USAN/INN); Xarelto (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07113 |
Loperamide oxide (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07117 |
Metahexamide (INN) |
(P) unclassified |
| D07118 |
Glisoxepide (INN) |
(P) unclassified |
| D07124 |
Alfuzosin (INN); Xatral (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07129 |
Alosetron (INN) |
(P) unclassified |
| D07131 |
Ethyl biscoumacetate (INN) |
(P) unclassified |
| D07132 |
Buprenorphine (JAN/INN); Temgesic (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07135 |
Clorindione (INN); G-25766 |
(P) unclassified |
| D07136 |
Diphenadione (INN) |
(P) unclassified |
| D07137 |
Tioclomarol (INN) |
(P) unclassified |
| D07138 |
Ditazole (INN) |
(P) unclassified |
| D07139 |
Cloricromen (INN) |
(P) unclassified |
| D07140 |
Picotamide (BAN); Plactidil (TN) |
(P) unclassified |
| D07141 |
Indobufen (INN) |
(P) unclassified |
| D07142 |
Triflusal (INN) |
(P) unclassified |
| D07143 |
Melagatran (INN) |
(P) unclassified |
| D07144 |
Dabigatran etexilate (USAN/INN); Pradaxa (TN) |
(P) unclassified |
| D07165 |
Ivabradine (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07166 |
Methoserpidine (INN) |
(P) unclassified |
| D07167 |
Bietaserpine (prop.INN) |
(P) unclassified |
| D07168 |
Tolonidine (INN) |
(P) unclassified |
| D07169 |
Guanazodine (INN) |
(P) unclassified |
| D07170 |
Dihydralazine (INN) |
(P) unclassified |
| D07171 |
Sitaxentan (USAN/INN) |
(P) unclassified |
| D07172 |
Mebutizide (INN) |
(P) unclassified |
| D07175 |
Palonosetron (INN); Aloxi (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07192 |
Benfluorex (INN/BAN); Mediaxal (TN) |
(P) unclassified |
| D07193 |
Flutrimazole (INN) |
(P) unclassified |
| D07203 |
Methylprednisolone aceponate (INN); Advantan (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D07226 |
Fesoterodine (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07242 |
Flurithromycin (INN) |
(P) unclassified |
| D07283 |
Esketamine (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07290 |
Dipyrocetyl (INN) |
(P) unclassified |
| D07291 |
Benorilate (INN); Benorylate |
(P) unclassified |
| D07292 |
Guacetisal (INN); Prontomucil (TN) |
(P) unclassified |
| D07293 |
Imidazole salicylate (INN); Selezen (TN) |
(P) unclassified |
| D07299 |
Lacosamide (JAN/USAN/INN); Erlosamide; Vimpat (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07402 |
Levocetirizine (USAN/INN); Xazal (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07407 |
Rupatadine (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07421 |
Aloxiprin (INN); Superpyrin (TN) |
(P) unclassified |
| D07422 |
Fibrinolysin (human) (INN); Fibrinolysin, human; Fibrogammin (TN) |
(P) unclassified |
| D07447 |
Amiloride (INN); Amiclaran (TN) |
(P) unclassified |
| D07448 |
Amitriptyline (INN); Laroxyl (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07450 |
Amlodipine (USP/INN); Norvasc (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07457 |
Anisindione (INN); Miradon (TN) |
(P) unclassified |
| D07471 |
Atazanavir (INN); Reyataz (TN) |
(P) CYP inhibition: CYP3A4 |
| D07474 |
Atorvastatin (INN); Lipitor (TN); Sortis (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07486 |
Azithromycin (INN); Azasite (TN); Azithromycin (TN) |
(P) unclassified |
| D07488 |
Balsalazide (INN) |
(P) unclassified |
| D07494 |
Barnidipine (INN); Vasexten (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07508 |
Benfluorex hydrochloride; Mediator (TN) |
(P) unclassified |
| D07509 |
Benidipine (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07510 |
Adomiparin (USAN); Semuloparin (USAN); Heparin (BAN); Enoxaparin; Bemiparin; Parnaparin; Nadroparin; Heparin (TN) |
(P) unclassified |
| D07520 |
Bepridil (INN); Bepadin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07538 |
Bosentan (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07552 |
Bupivacaine (USAN/INN); Bucaine (TN); Exparel (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07569 |
Candesartan cilexetil and anmlodipine besylate (JP18); Unisia (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07579 |
Aspirin calcium salt; Notras (TN) |
(P) unclassified |
| D07580 |
Aspirin DL-lysine (JAN); Aspirin lysine salt; Aspegic (TN) |
(P) unclassified |
| D07581 |
Aspirin magnesium salt; Mobidin (TN) |
(P) unclassified |
| D07582 |
Aspirin sodium; Sodium acetylsalicylate; Catalgine (TN) |
(P) unclassified |
| D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) unclassified |
| D07585 |
Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine; Cleamine A (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) CYP induction: CYP3A4 |
| D07598 |
Butoconazole (INN); Gynofort (TN) |
(P) unclassified |
| D07603 |
Caffeine citrate (USP); Cafcit (TN) |
(P) unclassified |
| D07612 |
Sodium salamidacetate; o-Carbamoylphenoxyacetic acid sodium salt; Clinit-n (TN) |
(P) unclassified |
| D07626 |
Caspofungin (INN); Cancidas (TN) |
(P) unclassified |
| D07661 |
Cerivastatin (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07667 |
Cevimeline (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07676 |
Chlormidazole hydrochloride; Unfungicid (TN) |
(P) unclassified |
| D07704 |
Citalopram (USP/INN); Citadur (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07705 |
Citalopram hydrochloride; Seropram (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07710 |
Clarithromycin lactobionate; Klacid (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D07727 |
Clomipramine (INN); Anafranil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07729 |
Clopidogrel (USP/INN); Clopidogrel (TN); Plavix (TN) |
(P) unclassified |
| D07736 |
Cloricromen hydrohloride; Proendotel (TN) |
(P) unclassified |
| D07740 |
Codeine hydrochloride; Bisoltus (TN) |
(P) unclassified |
| D07748 |
Conivaptan (INN) |
(P) unclassified |
| D07752 |
Croconazole (INN) |
(P) unclassified |
| D07760 |
Cyclophosphamide (INN); Cyclophosphamide (TN); Cytoxan (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07793 |
Desvenlafaxine (INN); Khedezla (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07796 |
Dexamethasone 21-acetate; Dexamethasone acetate anhydrous; Decaject-L.A. (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D07797 |
Dexamethasone isonicotinate; Dexamethasone 21-isonicotinate; Voren [veterinary] (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D07798 |
Dexamethasone sodium hemisulfate; Dexamethasone 21-sodium sulfate; Colircusi Dexametasona (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D07799 |
Dexamethasone 21-tebutate; Dexamethasone tertiary butyl acetate; Dexamedium [veterinary] (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D07800 |
Dexamethasone 21-valerate; Voalla (TN); Zalucs (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D07801 |
Dexamethasone phenylpropionate; Dexafort [veterinary] (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D07802 |
Dexamethasone phosphate; Decadron-phosphate (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D07824 |
Diethylamine salicylate; Algesal (TN) |
(P) unclassified |
| D07830 |
Dihydralazine sulfate; Dihydralazine hydrogen sulfate; Nepresol (TN) |
(P) unclassified |
| D07831 |
Dihydrocodeine (INN); Remedacen (TN) |
(P) unclassified |
| D07832 |
Dihydrocodeine thiocyanate; Paracodin (TN) |
(P) unclassified |
| D07837 |
Dihydroergotamine (INN); Neomigran (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07838 |
Dihydroergotamine tartrate; Divegal (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07839 |
Dihydroergotoxine; Co-Dergocrin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07845 |
Diltiazem (INN); Surazem (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07866 |
Docetaxel (JAN/INN); Docetaxel (TN); Taxotere (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07868 |
Domperidone maleate; Domperidone (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07869 |
Donepezil (JAN/INN); Donaz (TN); Allydone (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07871 |
Dorzolamide (INN); Trusopt (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07873 |
Doxapram (INN); Docatone (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07874 |
Doxazosin (INN); Cardura XL (TN) |
(P) unclassified |
| D07882 |
Eberconazole (INN) |
(P) unclassified |
| D07884 |
Eberconazole nitrate; Ebernet (TN) |
(P) unclassified |
| D07887 |
Eletriptan (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07895 |
Losartan potassium and hydrochlorothiazide (JP18); Hydrochlorothiazide and losartan potassium; Hyzaar (TN); Losarhyd (TN) |
(P) unclassified |
| D07905 |
Ergometrine (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07906 |
Ergotamine (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07907 |
Erlotinib (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07909 |
Erythromycin thiocyanate; Erythrocin (TN) |
(P) unclassified |
| D07910 |
Erythromycin stinoprate (INN); Erysec (TN) |
(P) unclassified |
| D07913 |
Escitalopram (INN); Esertia (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07917 |
Esomeprazole (INN); Inexium paranova (TN) |
(P) unclassified |
| D07918 |
Estradiol hemihydrate; Estrasorb (TN); Vagifem (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07919 |
Estradiol 17 beta-hemisuccinate; 17beta-Estradiol hemisuccinate; Eutocol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07928 |
Ethinylestradiol propanesulfonate; Turisteron (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D07929 |
Ethylmorphine (BAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07945 |
Fenfluramine (INN); Ponderax (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07955 |
Fenquizone potassium salt; Idrolone (TN) |
(P) unclassified |
| D07969 |
Fluindione (INN); Previsccan (TN) |
(P) unclassified |
| D07981 |
Fluticasone (INN); Fluticaps (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D07983 |
Fluvastatin (INN); Fluvas (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07991 |
Fosfosal (INN); Aydolid (TN) |
(P) unclassified |
| D07993 |
Fosphenytoin (INN) |
(P) CYP induction: CYP3A4 |
| D07999 |
Sodium furosemide; Frosemide sodium; Lasix (TN) |
(P) unclassified |
| D08001 |
Furosemide diolamine; Furosemide diethanolamine salt; Nuriban (TN) |
(P) unclassified |
| D08004 |
Gabexate (INN) |
(P) unclassified |
| D08030 |
Guanethidine (INN) |
(P) unclassified |
| D08031 |
Guanfacine (INN); Estulic (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08035 |
Haloperidol lactate; Haldol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08044 |
Hydralazine (INN); Hidral (TN) |
(P) unclassified |
| D08045 |
Hydrocodone (INN); Dihydrocodeinone |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08046 |
Hydrocodone hydrochloride; Dihydrocodeinone hydrochloride; Dicodid (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08050 |
Hydroxychloroquine (INN); Polirreumin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08065 |
Iloprost tromethamine; Iloprost trometamol; Ventavis (TN) |
(P) unclassified |
| D08066 |
Imatinib (INN); Glamox (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08070 |
Imipramine (INN); Tofranil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08071 |
Imipramine pamoate (USP); Imipramine embonate; Tofranil-pm (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08080 |
Insulin injection, biphasic isophane (BAN); Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP18); Insulin Humacart (TN) |
(P) unclassified |
| D08086 |
Irinotecan (INN); Biotecan (TN) |
(P) unclassified |
| D08095 |
Ivabradine hydrochloride (JAN/USAN); Ivabrandine hydrochloride; Corlanor (TN); Corlentor (TN); Coralan (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08099 |
Ketanserin tartrate; Sufrexal (TN) |
(P) unclassified |
| D08108 |
Lapatinib (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08116 |
Levobupivacaine (INN); Novabupi (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08118 |
Levocetirizine dihydrochloride (USP); Levocetirizine hydrochloride (JAN); Xyzal (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08127 |
Lidocaine hydrochloride monohydrate; Lidocaine (TN); Zingo (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08144 |
Loperamide (INN); Diamide (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08148 |
Loxapine hydrochloride; Desconex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08155 |
Manidipine (INN); Manidipine 6300; Artedil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08194 |
Deserpidine (INN); Halmonyl (TN) |
(P) unclassified |
| D08195 |
Methadone (BAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08205 |
Methyldopa (INN); Aldomet (TN) |
(P) unclassified |
| D08207 |
Methylergometrine (INN); Ergotyl (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08212 |
Trimazosin (INN) |
(P) unclassified |
| D08216 |
Mianserin (INN); Tolvon (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08227 |
Mometasone (INN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D08229 |
Montelukast (INN); Brondilat (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08236 |
Mosapride (INN); Mosart (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08240 |
Nafamostat (INN) |
(P) unclassified |
| D08254 |
Endralazine (INN) |
(P) unclassified |
| D08255 |
Naratriptan (INN); Naramig (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08256 |
Nateplase (INN); Milyzer (TN); Tepase (TN) |
(P) unclassified |
| D08259 |
Nelfinavir (INN); Viracept (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D08270 |
Nicardipine (INN); Cardene (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08283 |
Nordazepam (INN); Calmday (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08291 |
Ofloxacin hydrochloride; Tarivid (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08295 |
Olsalazine (INN) |
(P) unclassified |
| D08296 |
Omoconazole (INN) |
(P) unclassified |
| D08313 |
Oxiconazole (INN) |
(P) unclassified |
| D08327 |
Ozagrel (INN); Cataclot (TN) |
(P) unclassified |
| D08351 |
Phenformin (BAN) |
(P) unclassified |
| D08352 |
Phenformin hydrochloride; Debei (TN) |
(P) unclassified |
| D08354 |
Phenindione (INN); Hedulin (TN) |
(P) unclassified |
| D08356 |
Phenobarbital diethylamine; Gratusminal (TN) |
(P) unclassified |
| D08378 |
Pioglitazone (INN); Actos (TN) |
(P) unclassified |
| D08408 |
Pranlukast (INN); Azlaire (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08411 |
Prazosin (INN); Minipress (TN) |
(P) unclassified |
| D08424 |
Procaterol (INN); Meptin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08435 |
Propafenone (INN); Propafenon hexal (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08441 |
Propiverine (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08453 |
Pargyline (INN) |
(P) unclassified |
| D08456 |
Quetiapine (INN); Norsic (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08460 |
Quinine (BAN); Kinder Quinina (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08461 |
Quinine dihydrochloride; Quinine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08463 |
Rabeprazole (INN); Eraloc (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08479 |
Rifampicin sodium; Rifadine (TN) |
(P) CYP induction: CYP3A4 |
| D08481 |
Rilmazafone (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08482 |
Rilmenidine (INN); Hyperium (TN) |
(P) unclassified |
| D08488 |
Amlodipine besilate and atorvastatin calcium; Caduet (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08490 |
Ropivacaine (INN); Naropin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08491 |
Rosiglitazone (INN); Gaudil (TN) |
(P) unclassified |
| D08493 |
Dorzolamide hydrochloride and timolol maleate (JP18); Cosopt (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08497 |
Rupatadine fumarate (JAN); Rinialer (TN); Rupafin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08501 |
Trolamine salicylate (USP); Salicylic acid trolamine; Salicylic acid triethanolamine; Arthricream (TN) |
(P) unclassified |
| D08508 |
Sarpogrelate (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08510 |
Sertaconazole nitrate; Ertaczo (TN); Zalain (TN) |
(P) unclassified |
| D08514 |
Sildenafil (INN); Aphrodil (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08516 |
Sitagliptin (USAN/INN) |
(P) unclassified |
| D08517 |
Sitaxentan sodium (USAN); Thelin (TN) |
(P) unclassified |
| D08522 |
Solifenacin (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08527 |
Spiramycin adipate; Rovamycina (TN); Spiramaicina (TN) |
(P) unclassified |
| D08528 |
Spiramycin embonate; Cofamix STS (TN) |
(P) unclassified |
| D08535 |
Sulconazole (INN) |
(P) unclassified |
| D08536 |
Suleparoid; Heparitin sulfate; Aremin (TN) |
(P) unclassified |
| D08547 |
Sulodexide (INN); Vessel (TN) |
(P) unclassified |
| D08552 |
Sunitinib (INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08556 |
Tacrolimus (INN); Prograf (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08559 |
Tamoxifen (INN); Tamoxifen (TN); Tamoplex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08575 |
Tetrabenazine (JAN/INN); Nitoman (TN); Xenazine (TN) |
(P) unclassified |
| D08586 |
Thiosalicylic acid; Pirosal (TN); Thiocyl (TN) |
(P) unclassified |
| D08594 |
Ticlopidine (INN); Ticlopidin-Puren (TN) |
(P) unclassified |
| D08605 |
Tipranavir (INN); Aptivus (TN) |
(P) unclassified |
| D08607 |
Tirofiban (INN); Agrastat (TN) |
(P) unclassified |
| D08609 |
Tisokinase (JAN) |
(P) unclassified |
| D08616 |
Teneligliptin (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D08619 |
Torasemide sodium; Torem (TN) |
(P) unclassified |
| D08620 |
Toremifene (INN); Fareston (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08623 |
Tramadol (INN); Amanda (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08626 |
Trazodone (INN); Trittico (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08628 |
Treprostinil monosodium salt; Treprostinil sodium; Trepulmix (TN) |
(P) unclassified |
| D08631 |
Carmegliptin (USAN/INN) |
(P) unclassified |
| D08662 |
Urapidil hydrochloride; Ebrantil (TN) |
(P) unclassified |
| D08668 |
Vardenafil (USAN/INN); Levitra (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08670 |
Venlafaxine (INN); Efectin (TN) |
(P) unclassified |
| D08675 |
Vinblastine (INN); Vinblastina (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08680 |
Vinorelbine (INN); Navelbine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08682 |
Warfarin (INN); Warfarine; Choice (TN) |
(P) unclassified |
| D08690 |
Zolpidem (INN); Sanval (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08695 |
dl-Methylephedrine hydrochloride, dihydrocodeine phosphate, diprophylline, diphenhydramine salicylate, acetaminophen and bromovalerylurea; Coughcode N (TN) |
(P) unclassified |
| D08697 |
Platycodon fluidextract, glycyrrhiza extract, plantago herb extract, peony root extract and dihydrocodeine phosphate; Opisezol codeine (TN) |
(P) unclassified |
| D08699 |
Salmeterol xinafoate and fluticasone propionate; Adoair diskus (TN); Aerivio Spiromax (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08774 |
Amoxicillin hydrate, clarithromycin and lansoprazole; Lansap (TN); Prevpac (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D08777 |
Freeze-dried live attenuated varicella vaccine |
(CI) unclassified |
| D08795 |
Human antithrombin III, freeze-dried concentrated; Neuart (TN) |
(P) unclassified |
| D08804 |
Freeze-dried live attenuated measles-rubella combined vaccine; Mearubik (TN) |
(CI) unclassified |
| D08843 |
Albiglutide (USAN); Albiglutide (genetical recombination) (JAN); Tanzeum (TN) |
(P) unclassified |
| D08856 |
Anamorelin hydrochloride (JAN/USAN); Adlumiz (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08858 |
Antithrombin alfa (INN/USAN); Atryn (TN) |
(P) unclassified |
| D08860 |
Apremilast (JAN/USAN); Otezla (TN) |
(P) unclassified |
| D08870 |
Belinostat (USAN/INN); Beleodaq (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08873 |
Betrixaban (USAN); Bevyxxa (TN) |
(P) unclassified |
| D08897 |
Dapagliflozin (JAN/USAN/INN); Forxiga (TN) |
(P) unclassified |
| D08903 |
Dexlansoprazole (INN/USAN); Dexilant (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08913 |
Eribaxaban (USAN) |
(P) unclassified |
| D08914 |
Eribulin mesylate (USAN); Eribulin mesilate (JAN); Halaven (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08923 |
Fesoterodine fumarate (JAN/USAN); Toviaz (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08950 |
Neratinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08953 |
Nilotinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08962 |
Pamabrom (USP) |
(P) unclassified |
| D08969 |
Pimavanserin tartrate (USAN); Nuplazide (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08976 |
Pomalidomide (JAN/USAN/INN); Pomalyst (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08988 |
Rolapitant hydrochloride (USAN); Varubi (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D08996 |
Saxagliptin (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09012 |
Telaprevir (JAN/USAN/INN); Incivek (TN); Incivo (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D09013 |
Teplizumab (USAN/INN); Teplizumab-mzwv; Tzield (TN) |
(P) unclassified |
| D09017 |
Ticagrelor (JAN/USAN/INN); Brilinta (TN) |
(CI,P) unclassified |
| D09033 |
Voclosporin (JAN/USAN/INN); Lupkynis (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09187 |
Estradiol and levonorgestrel; Wellnara (TN); Climara pro (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09188 |
Estradiol and norethindrone; Menoaid (TN); Activella (TN); Combipatch (TN); Estradiol and norethindrone acetate (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09196 |
Candesartan cilexetil and hydrochlorothiazide (JP18); Ecard HD (TN); Ecard LD (TN) |
(P) unclassified |
| D09197 |
Valsartan and hydrochlorothiazide (JP18); Co-dio (TN) |
(P) unclassified |
| D09206 |
Saruplase (INN); Prourokinase (enzyme activating) (human clone pUK4/pUK18), nonglycosylated |
(P) unclassified |
| D09215 |
Eslicarbazepine (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D09219 |
Telmisartan and hydrochlorothiazide (JP18); Micombi (TN); Micardis hct (TN) |
(P) unclassified |
| D09318 |
Indacaterol (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09319 |
Indacaterol maleate (JAN/USAN); Arcapta neohaler (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09326 |
Carmegliptin dihydrochloride (USAN) |
(P) unclassified |
| D09333 |
Dutogliptin (USAN) |
(P) unclassified |
| D09334 |
Dutogliptin tartrate (USAN) |
(P) unclassified |
| D09339 |
Esomeprazole potassium (USAN) |
(P) unclassified |
| D09347 |
Fostamatinib (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09348 |
Fostamatinib disodium (USAN); Fostamatinib sodium hydrate (JAN); Fostamatinib disodium hexahydrate; Tavalisse (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09365 |
Palovarotene (JAN/USAN/INN); Sohonos (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09388 |
Tasimelteon (USAN/INN); Hetlioz (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09394 |
Fidaxomicin (JAN/USAN); Dificid (TN); Dificlir (TN) |
(P) CYP inhibition: CYP3A4 |
| D09535 |
Mirabegron (JAN/USAN/INN); Myrbetriq (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09544 |
Ozenoxacin (JAN/USAN/INN); Xepi (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09546 |
Edoxaban tosilate hydrate (JAN); Edoxaban tosylate monohydrate; Lixiana (TN); Savaysa (TN) |
(P) unclassified |
| D09566 |
Linagliptin (JAN/USAN/INN); Tradjenta (TN) |
(P) unclassified |
| D09572 |
Riociguat (JAN/USAN/INN); Adempas (TN) |
(P) unclassified |
| D09592 |
Canagliflozin (USAN/INN); Canagliflozin hydrate (JAN); Invokana (TN) |
(P) unclassified |
| D09594 |
Olmesartan medoxomil and azelnidipine; Rezaltas (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09595 |
Budesonide and formoterol fumarate dihydrate; Symbicort (TN); Budeforu (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09605 |
Duvoglustat (USAN/INN); 1-Deoxynojirimycin |
(P) unclassified |
| D09606 |
Duvoglustat hydrochloride (USAN) |
(P) unclassified |
| D09612 |
Eslicarbazepine acetate (USAN); Zebinix (TN); Aptiom (TN) |
(P) CYP induction: CYP3A4 |
| D09625 |
Gosogliptin (USAN/INN) |
(P) unclassified |
| D09637 |
Lomitapide (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09642 |
Modithromycin (USAN/INN) |
(P) unclassified |
| D09666 |
Selumetinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09676 |
Tecarfarin (USAN/INN) |
(P) unclassified |
| D09677 |
Tecarfarin sodium (USAN) |
(P) unclassified |
| D09683 |
Tivozanib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09698 |
Vilazodone (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09699 |
Vilazodone hydrochloride (USAN); Viibryd (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09701 |
Abiraterone acetate (JAN/USP); Zytiga (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09702 |
Albaconazole (USAN/INN) |
(P) unclassified |
| D09707 |
Dabigatran (USAN/INN) |
(P) unclassified |
| D09710 |
Edoxaban (USAN/INN) |
(P) unclassified |
| D09720 |
Rilpivirine (JAN/USAN/INN); Rekambys (TN) |
(CI) unclassified |
| D09723 |
Taspoglutide (USAN/INN) |
(P) unclassified |
| D09727 |
Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN); Tresiba (TN) |
(P) unclassified |
| D09728 |
Bosutinib hydrate (JAN); Bosutinib monohydrate; Bosulif (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09729 |
Lixisenatide (JAN/USAN/INN); Adlyxin (TN); Lyxumia (TN) |
(P) unclassified |
| D09730 |
Olaparib (JAN/USAN/INN); Lynparza (TN) |
(P) unclassified |
| D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09736 |
Iron (III) hexacyanoferrate (II); Radiogardase (TN) |
(P) unclassified |
| D09741 |
Drospirenone and ethinylestradiol; Drospirenone and ethinylestradiol betadex; Angeliq (TN); Yaz (TN); Flexyess (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09742 |
Lansoprazole, amoxicillin hydrate and metronidazole; Lampion (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09743 |
Telmisartan and amlodipine besilate (JP18); Telmisartan and amlodipine besylate; Micamlo (TN); Twynsta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09744 |
Pioglitazone hydrochloride and metformin hydrochloride (JP18); Pioglitazone and metformin; Metact (TN) |
(P) unclassified |
| D09745 |
Valsartan and amlodipine besilate; Exforge (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09753 |
Saxagliptin hydrate (JAN); Onglyza (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09756 |
Teneligliptin hydrobromide hydrate (JAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D09763 |
Dapagliflozin propanediol (USAN); Dapagliflozin propylene glycolate hydrate (JAN); Dapagliflozin propandiol monohydrate; Forxiga (TN); Farxiga (TN) |
(P) unclassified |
| D09765 |
Vorapaxar (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09766 |
Vorapaxar sulfate (JAN/USAN); Zontivity (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09772 |
Alilusem potassium (JAN); M17055 |
(P) unclassified |
| D09779 |
Emiglitate (JAN/INN) |
(P) unclassified |
| D09780 |
Anagliptin (JAN/INN) |
(P) unclassified |
| D09783 |
Tofacitinib citrate (JAN/USAN); Tasocitinib citrate; Xeljanz (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09785 |
Delamanid (JAN/USAN); Deltyba (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09799 |
Carotegrast methyl (JAN); Carogra (TN) |
(P) CYP inhibition: CYP3A4 |
| D09807 |
Difethiarol (JAN); Difethialone |
(P) unclassified |
| D09809 |
Tylosin acetate isovalerte (JAN) |
(P) unclassified |
| D09814 |
Silteplase (INN); Silteplase (genetical recombination) (JAN) |
(P) unclassified |
| D09817 |
Darexaban maleate (JAN); YM150 |
(P) unclassified |
| D09823 |
Duteplase (INN); Duteplase (genetical recombination) (JAN) |
(P) unclassified |
| D09848 |
Pioglitazone hydrochloride and glimepiride tablets (JP18); Pioglitazone and glimepiride; Duetact; Sonias (TN) |
(P) unclassified |
| D09872 |
Bedaquiline (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09873 |
Bedaquiline fumarate (JAN/USAN); Sirturo (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09876 |
Cariprazine hydrochloride (JAN/USAN); Vraylar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09889 |
Dulaglutide (USAN/INN); Dulaglutide (genetical recombination) (JAN); Trulicity (TN) |
(P) unclassified |
| D09893 |
Eliglustat (USAN/INN) |
(P) unclassified |
| D09894 |
Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) |
(P) unclassified |
| D09920 |
Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN); Lenvima (TN) |
(P) unclassified |
| D09923 |
Letaxaban (USAN/INN) |
(P) unclassified |
| D09951 |
Ponatinib hydrochloride (JAN/USAN); Iclusig (TN) |
(P) unclassified |
| D09956 |
Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN); Vanflyta (TN) |
(P) unclassified |
| D09958 |
Rilpivirine hydrochloride (JAN/USAN); Edurant (TN) |
(CI) unclassified |
| D09959 |
Ruxolitinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09960 |
Ruxolitinib phosphate (JAN/USAN); Jakafi (TN); Jakavi (TN); Opzelura (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09970 |
Tofacitinib (USAN); Tasocitinib |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09978 |
Tofogliflozin (USAN); Tofogliflozin hydrate (JAN); Apleway (TN); Deberza (TN) |
(P) unclassified |
| D09989 |
Vardenafil hydrochloride (USP) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09994 |
Selexipag (JAN/USAN/INN); Uptravi (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) CYP induction: CYP3A4 |
| D09997 |
Cariprazine (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D09999 |
Tramadol hydrochloride and acetaminophen; Tramcet (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10003 |
Hemin (JAN); Normosang (TN); Panhematin (TN) |
(P) CYP induction: CYP3A4 |
| D10019 |
Panobinostat lactate (JAN); Farydak (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10021 |
Efinaconazole (JAN/USAN/INN); Clenafin (TN); Jublia (TN) |
(P) unclassified |
| D10024 |
Selumetinib sulfate (JAN/USAN); Koselugo (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10025 |
Semaglutide (USAN/INN); Semaglutide (genetical recombination) (JAN); Ozempic (TN) |
(P) unclassified |
| D10032 |
Tylvalosin (USAN/INN) |
(P) unclassified |
| D10033 |
Tylosin tartrate (USP) |
(P) unclassified |
| D10034 |
Tylvalosin tartrate (USAN); Aiviosin [veterinary] (TN) |
(P) unclassified |
| D10055 |
Remogliflozin etabonate (USAN/INN) |
(P) unclassified |
| D10064 |
Dabrafenib (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10065 |
Daclatasvir (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10066 |
Dolutegravir (USAN); Tivicay (TN) |
(P) unclassified |
| D10082 |
Suvorexant (JAN/USAN); MK-4305; Belsomra (TN) |
(P) unclassified |
| D10093 |
Asunaprevir (JAN/USAN); Sunvepra (TN) |
(P) CYP induction: CYP3A4 |
| D10095 |
Cabozantinib s-malate (USAN); Cabozantinib malate (JAN); Cometriq (TN); Cabometyx (TN) |
(P) unclassified |
| D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10105 |
Daclatasvir dihydrochloride (USAN); Daclatasvir hydrochloride (JAN); Daklinza (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10113 |
Dolutegravir sodium (JAN/USAN); Tivicay (TN) |
(P) unclassified |
| D10120 |
Esomeprazole strontium (USAN); Esomeprazole strontium tetrahydrate; Esomeprazole strontium (TN) |
(P) unclassified |
| D10131 |
Ixazomib citrate (JAN/USAN); Ninlaro (TN) |
(P) unclassified |
| D10135 |
Macitentan (JAN/USAN); Opsumit (TN) |
(CI,P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10137 |
Regorafenib hydrate (JAN); Stivarga (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10138 |
Regorafenib (USAN/INN); Stivarga (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10158 |
Safinamide (USAN/INN) |
(P) unclassified |
| D10159 |
Alogliptin benzoate and pioglitazone hydrochloride; Liovel (TN); Oseni (TN); Incresync (TN) |
(P) unclassified |
| D10160 |
Mitiglinide calcium hydrate and voglibose; Glubes (TN) |
(P) unclassified |
| D10161 |
Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) |
(P) unclassified |
| D10178 |
Trelagliptin (USAN) |
(P) unclassified |
| D10179 |
Trelagliptin succinate (JAN/USAN); Zafatek (TN) |
(P) unclassified |
| D10184 |
Vortioxetine (USAN); Brintellix (TN) |
(P) unclassified |
| D10185 |
Vortioxetine hydrobromide (JAN/USAN); Brintellix (TN); Trintellix (TN) |
(P) unclassified |
| D10188 |
Naldemedine (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10190 |
Tivozanib hydrochloride (USAN); Tivozanib hydrochloride monohydrate; Fotivda (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10191 |
Safinamide mesylate (USAN); Safinamide mesilate (JAN); Safinamide methanesulfonate; Xadago (TN); Equfina (TN) |
(P) unclassified |
| D10192 |
Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine (yeast origin); Gardasil (TN); Silgard (TN) |
(P) unclassified |
| D10195 |
Luseogliflozin hydrate (JAN); Lusefi (TN) |
(P) unclassified |
| D10196 |
Ipragliflozin (INN) |
(P) unclassified |
| D10200 |
Ipragliflozin L-proline (JAN); Suglat (TN) |
(P) unclassified |
| D10218 |
Enzalutamide (JAN/USAN); Xtandi (TN) |
(P) unclassified |
| D10223 |
Ibrutinib (JAN/USAN); Imbruvica (TN) |
(P) unclassified |
| D10243 |
Irbesartan and amlodipine besilate (JP18); Aimix (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10244 |
Metformin hydrochloride and rosiglitazone maleate; Avandamet (TN) |
(P) unclassified |
| D10246 |
Omeprazole, clarithromycin and amoxicillin; Omeclamox-pak (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D10251 |
Glimepiride and rosiglitazone maleate; Avandaryl (TN) |
(P) unclassified |
| D10253 |
Alogliptin benzoate and metformin hydrochloride; Kazano (TN); Vipdomet (TN) |
(P) unclassified |
| D10258 |
Simvastatin and sitagliptin phosphate; Juvisync (TN) |
(P) unclassified |
| D10261 |
Metformin hydrochloride and sitagliptin phosphate; Janumet (TN) |
(P) unclassified |
| D10262 |
Saxagliptin hydrochloride; Onglyza (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10263 |
Metformin hydrochloride and saxagliptin hydrochloride; Kombiglyze (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10264 |
Linagliptin and metformin hydrochloride; Jentaduet (TN) |
(P) unclassified |
| D10265 |
Glipizide and metformin hydrochloride; Metaglip (TN) |
(P) unclassified |
| D10266 |
Glyburide and metformin hydrochloride; Glibenclamide and metformin hydrochloride; Glucovance (TN) |
(P) unclassified |
| D10267 |
Methyldopa and hydrochlorothiazide; Methyldopa and hydrochlorothiazide (TN) |
(P) unclassified |
| D10306 |
Avatrombopag (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10307 |
Avatrombopag maleate (JAN/USAN); Doptelet (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10309 |
Brexpiprazole (JAN/USAN/INN); Rexulti (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10313 |
Ertugliflozin (USAN/INN) |
(P) unclassified |
| D10315 |
Momelotinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10317 |
Omarigliptin (JAN/USAN/INN) |
(P) unclassified |
| D10319 |
Panobinostat (USAN/INN); Farydak (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10355 |
Aripiprazole cavoxil (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10358 |
Momelotinib dihydrochloride (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10364 |
Aripiprazole lauroxil (USAN); Aristada (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
| D10385 |
Ezetimibe and atorvastatin; Atozet (TN); Liptruzet (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10430 |
Treprostinil diolamine (USAN); Orenitram (TN) |
(P) unclassified |
| D10433 |
Vibegron (JAN/USAN/INN); Beova (TN); Gemtesa (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10450 |
Alectinib hydrochloride (JAN); Alecensa (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10452 |
Cabazitaxel acetonate (JAN); Cabazitaxel acetone; Jevtana (TN) |
(P) unclassified |
| D10459 |
Empagliflozin (JAN/USAN/INN); Jardiance (TN) |
(P) unclassified |
| D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10471 |
Idraparinux sodium (USAN) |
(P) unclassified |
| D10473 |
Insulin peglispro (USAN/INN) |
(P) unclassified |
| D10478 |
Naldemedine tosylate (JAN/USAN); Naldemedine tosilate; Symproic (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10480 |
Irbesartan and trichlormethiazide; Irtra (TN) |
(P) unclassified |
| D10492 |
Tildipirosin (USAN/INN); Zuprevo [veterinary] (TN) |
(P) unclassified |
| D10500 |
Metformin hydrochloride and repaglinide; Prandimet (TN) |
(P) unclassified |
| D10501 |
Fluticasone furoate and vilanterol trifenatate; Breo ellipta (TN); Relvar ellipita (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10502 |
Gemigliptin (INN) |
(P) unclassified |
| D10505 |
Glycopyrronium bromide and indacaterol maleate; Ultibro (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10506 |
Fluticasone propionate and formoterol fumarate hydrate; Flutiform (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10512 |
Brinzolamide and timolol maleate; Azorga (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10513 |
Clopidogrel sulfate and aspirin; Clopidogrel and acetylsalicyclic acid; Complavin (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10516 |
Aripiprazole hydrate (JAN); Aripiprazole monohydrate; Abilify maintena (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10519 |
Rabeprazole, amoxicillin and clarithromycin; Rabecure (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D10520 |
Rabeprazole, amoxicillin and metronidazole; Rabefine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10524 |
Azilsartan and amlodipine besilate; Zacras (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10525 |
Valsartan and cilnidipine; Atedio (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10527 |
Acetylsalicylic acid and lansoprazole; Acetylsalicylic acid and lansoprazole; Takelda (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10533 |
Umeclidinium bromide and vilanterol; Anoro (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10542 |
Alectinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) unclassified |
| D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) unclassified |
| D10566 |
Pasireotide pamoate (JAN); Signifor lar (TN) |
(P) unclassified |
| D10570 |
Insulin degludec (genetical recombination) and insulin aspart (genetical recombination); Ryzodeg (TN) |
(P) unclassified |
| D10572 |
Fosnetupitant and palonosetron hydrochloride; Netupitant and palonosetron hydrochloride; Akynzeo (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10586 |
Dapagliflozin and metformin; Xigduo xr (TN) |
(P) unclassified |
| D10587 |
Canagliflozin and metformin; Invokamet (TN) |
(P) unclassified |
| D10588 |
Empagliflozin and linagliptin; Glyxambi (TN) |
(P) unclassified |
| D10591 |
Clonidine and chlorthalidone; Clorpres (TN) |
(P) unclassified |
| D10600 |
Dolutegravir, abacavir and lamivudine; Triumeq (TN) |
(P) unclassified |
| D10612 |
Benzhydrocodone (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10627 |
Esketamine hydrochloride (JAN/USAN); Spravato (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10630 |
Fedratinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10633 |
Finerenone (JAN/USAN/INN); Kerendia (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10642 |
Irinotecan sucrosofate (USAN) |
(P) unclassified |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) unclassified |
| D10662 |
Rimegepant (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10663 |
Rimegepant sulfate (USAN); Nurtec odt (TN); Vydura (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10669 |
Sotagliflozin (USAN/INN); Inpefa (TN) |
(P) unclassified |
| D10673 |
Ubrogepant (USAN/INN); Ubrelvy (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10675 |
Valbenazine (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10676 |
Etelcalcetide (USAN/INN); Velcalcetide |
(P) unclassified |
| D10677 |
Etelcalcetide hydrochloride (JAN/USAN); Velcalcetide hydrochloride (USAN); Parsabiv (TN) |
(P) unclassified |
| D10679 |
Venetoclax (JAN/USAN/INN); Venclexta (TN) |
(P) unclassified |
| D10684 |
Antithrombin gamma (INN); Antithrombin gamma (genetical recombination) (JAN); Acoalan (TN) |
(P) unclassified |
| D10688 |
Abemaciclib (JAN/USAN/INN); Verzenio (TN) |
(P) unclassified |
| D10692 |
Benzhydrocodone hydrochloride (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10696 |
Capmatinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10709 |
Gilteritinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10711 |
Pemafibrate (JAN); Parmodia (TN) |
(P) unclassified |
| D10742 |
Rolapitant (USAN/INN); Varubi (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10743 |
Vildagliptin and metformin hydrochloride |
(P) unclassified |
| D10744 |
Tiotropium and olodaterol; Spiolto (TN); Stiolto respimat (TN) |
(P) unclassified |
| D10745 |
Ombitasvir, paritaprevir and ritonavir; Technivie (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D10746 |
Esflurbiprofen and mentha oil; Loqoa (TN) |
(P) unclassified |
| D10749 |
Pitolisant (USAN/INN); Wakix (TN); Ozawade (TN) |
(P) unclassified |
| D10750 |
Isavuconazole (INN); Cresemba (TN) |
(P) unclassified |
| D10752 |
Empagliflozin and metformin; Synjardy (TN) |
(P) unclassified |
| D10753 |
Atazanavir and cobicistat; Evotaz (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10755 |
Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide; Genvoya (TN) |
(P) unclassified |
| D10762 |
Fosravuconazole L-lysine ethanolate (JAN) |
(P) unclassified |
| D10766 |
Osimertinib mesylate (USAN); Osimertinib mesilate (JAN); Tagrisso (TN) |
(P) unclassified |
| D10772 |
Lascufloxacin hydrochloride (JAN); Lasvic (TN) |
(P) unclassified |
| D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D10780 |
Perampanel hydrate (JAN); Fycompa (TN) |
(P) unclassified |
| D10793 |
Sodium picosulfate hydrate, magnesium oxide and citric acid, anhydrous; Picoprep (TN); Prepopik (TN); Clenpiq (TN) |
(P) unclassified |
| D10800 |
Gilteritinib fumarate (JAN/USAN); Xospata (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10801 |
Letermovir (JAN/USAN/INN); Prevymis (TN) |
(P) unclassified |
| D10805 |
Telmisartan, amlodipine and hydrochlorothiazide; Micatrio (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10811 |
Fentanyl hydrochloride (JAN); Ionsys (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10823 |
Clopidogrel hydrochloride; Clopidogrel (TN) |
(P) unclassified |
| D10824 |
Clopidogrel besilate; Clopidogrel besylate; Clopidogrel (TN) |
(P) unclassified |
| D10826 |
Saxagliptin and dapagliflozin; Qtern (TN) |
(P) unclassified |
| D10827 |
Sofosbuvir and velpatasvir; Epclusa (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10832 |
Darunavir and cobicistat; Prezcobix (TN); Rezolsta (TN) |
(P) unclassified |
| D10836 |
Emtricitabine, rilpivirine and tenofovir alafenamide; Odefsey (TN) |
(CI) unclassified |
| D10865 |
Bexagliflozin (USAN); Brenzavvy (TN) |
(P) unclassified |
| D10866 |
Brigatinib (JAN/USAN); Alunbrig (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10882 |
Daclatasvir, asunaprevir and beclabuvir; Ximency (TN) |
(P) CYP induction: CYP3A4 |
| D10883 |
Ribociclib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10889 |
Momelotinib hydrochloride hydrate (JAN); Momelotinib dihydrochloride monohydrate; Ojjaara (TN); Omjjara (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10891 |
Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN); Tabrecta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10892 |
Esaxerenone (JAN/INN) |
(P) unclassified |
| D10893 |
Acalabrutinib (JAN/USAN/INN); Calquence (TN) |
(P) unclassified |
| D10895 |
Fosaprepitant (INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D10897 |
Teneligliptin and canagliflozin; Teneligliptin and canagliflozin; Canalia (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10898 |
Neratinib maleate; Nerlynx (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10915 |
Cannabidiol (USAN/INN); CBD; Epidiolex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10927 |
Erdafitinib (JAN/USAN/INN); Balversa (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10930 |
Etrasimod (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10931 |
Etrasimod arginine (USAN); Etrasimod L-arginine (JAN); Velsipity (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10954 |
Mirvetuximab soravtansine (USAN/INN); Mirvetuximab soravtansine-gynx; Elahere (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10960 |
Nirogacestat (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10970 |
Pegapamodutide (USAN/INN) |
(P) unclassified |
| D10979 |
Ribociclib succinate (USAN); Kisqali (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10990 |
Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) |
(P) unclassified |
| D10994 |
Upadacitinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10995 |
Upadacitinib tartrate (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10999 |
Valbenazine tosylate (USAN); Valbenazine tosilate (JAN); Valbenazine ditosylate; Ingrezza (TN); Dysval (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11000 |
Vamorolone (USAN/INN); Agamree (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D11009 |
Indacaterol acetate (JAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) unclassified |
| D11022 |
Lemborexant (JAN/USAN/INN); Dayvigo (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11023 |
Evogliptin (INN) |
(P) unclassified |
| D11029 |
Andexanet alfa (USAN/INN); Andexanet alfa (genetical recombination) (JAN); Andexxa (TN); Ondexxya (TN) |
(P) unclassified |
| D11034 |
Insulin glargine and lixisenatide; Insulin glargine (genetical recombination) and lixisenatide; Soliqua (TN) |
(P) unclassified |
| D11036 |
Glycopyrrolate and formoterol; Bevespi (TN) |
(P) unclassified |
| D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11043 |
Ertugliflozin pidolate; Ertugliflozin L-pyroglutamic acid; Steglatro (TN) |
(P) unclassified |
| D11045 |
Darolutamide (JAN/USAN/INN); Nebeqa (TN) |
(P) unclassified |
| D11048 |
Upadacitinib hydrate (JAN); Upadacitinib hemihydrate; Rinvoq (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11053 |
Encorafenib (JAN/USAN/INN); Braftovi (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11056 |
Mirtazapine hydrate (JAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11061 |
Osilodrostat (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11062 |
Osilodrostat phosphate (JAN/USAN); Isturisa (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11063 |
Evocalcet (JAN/INN); Orkedia (TN) |
(P) unclassified |
| D11064 |
Sitagliptin and ipragliflozin; Sujanu (TN) |
(P) unclassified |
| D11066 |
Ertugliflozin and sitagliptin; Steglujan (TN) |
(P) unclassified |
| D11067 |
Ertugliflozin and metformin; Segluromet (TN) |
(P) unclassified |
| D11070 |
Tirabrutinib hydrochloride (JAN/USAN); Velexbru (TN) |
(P) unclassified |
| D11072 |
Siponimod fumarate (USAN); Siponimod fumaric acid (JAN); Mayzent (TN) |
(P) unclassified |
| D11073 |
Tepotinib hydrochloride (USAN); Tepotinib hydrochloride hydrate (JAN); Tepmetko (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11093 |
Avacopan (JAN/USAN/INN); Tavneos (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11095 |
Atorvastatin calcium propylene glycol solvate |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11109 |
Anagliptin and Metformin hydrochloride |
(P) unclassified |
| D11114 |
Esomeprazole magnesium dihydrate |
(P) unclassified |
| D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
| D11150 |
Cenobamate (USAN/INN); Xcopri (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11158 |
Leniolisib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11159 |
Leniolisib phosphate (USAN); Joenja (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11160 |
Caplacizumab (USAN/INN); Caplacizumab (genetical recombination) (JAN); Caplacizumab-yhdp; Cablivi (TN) |
(P) unclassified |
| D11194 |
Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) |
(P) unclassified |
| D11222 |
Selinexor (USAN/INN); Xpovio (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11252 |
Fexinidazole (USAN/INN); Fexinidazole (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11270 |
Pexidartinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11271 |
Pexidartinib hydrochloride (JAN/USAN); Turalio (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11280 |
Bivalirudin trifluoroacetate (USAN); Angiomax (TN) |
(P) unclassified |
| D11282 |
Dolutegravir sodium and rilpivirine hydrochloride; Juluca (TN) |
(CI) unclassified |
| D11296 |
Fedratinib hydrochloride (USAN); Fedratinib hydrochloride hydrate (JAN); Fedratinib dihydrochloride monohydrate; Inrebic (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11313 |
Atogepant (USAN); Qulipta (TN); Aquipta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11330 |
Voxelotor (USAN); Oxbryta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11342 |
Dorzagliatin (USAN) |
(P) unclassified |
| D11360 |
Tirzepatide (JAN/USAN); Mounjaro (TN) |
(P) unclassified |
| D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
| D11371 |
Capivasertib (JAN/USAN); Truqap (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11382 |
Darunavir, cobicistat, emtricitabine and tenofovir alafenamide; Symtuza (TN) |
(P) unclassified |
| D11389 |
Dutasteride and tamsulosin; Jalyn (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11403 |
Asciminib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11404 |
Asciminib hydrochloride (JAN/USAN); Scemblix (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11406 |
Risdiplam (JAN/USAN/INN); Evrysdi (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11417 |
Pemigatinib (JAN/USAN/INN); Pemazyre (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11441 |
Aprocitentan (USAN/INN); Tryvio (TN) |
(P) unclassified |
| D11453 |
Nirogacestat hydrobromide (USAN); Ogsiveo (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11454 |
Repotrectinib (JAN/USAN); Augtyro (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11460 |
Siponimod (USAN/INN) |
(P) unclassified |
| D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
| D11490 |
Pitolisant hydrochloride (USAN); Wakix (TN) |
(P) unclassified |
| D11553 |
Lidocaine and tetracaine; Pliaglis (TN); Synera (TN) |
(P) unclassified |
| D11564 |
Upacicalcet sodium hydrate (JAN); Upasita (TN) |
(P) unclassified |
| D11567 |
Insulin degludec and liraglutide; Xultophy (TN) |
(P) unclassified |
| D11568 |
Edoxaban tosylate (USAN) |
(P) unclassified |
| D11572 |
Beclomethasone dipropionate monohydrate; Beconase aq (TN) |
(P) Enzyme: CYP3A4 / Target: NR3C1 / CYP induction: CYP3A4 |
| D11573 |
Oxycodone and ibuprofen |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11576 |
Naproxen and esomeprazole magnesium; Vimovo (TN) |
(P) unclassified |
| D11584 |
Budesonide, glycopyrronium bromide and formoterol fumarate; Budesonide, glycopyrrolate and formoterol fumarate; Breztri (TN) |
(P) unclassified |
| D11603 |
Leriglitazone (USAN/INN); 1-Hydroxypioglitazone |
(P) unclassified |
| D11604 |
Leriglitazone hydrochloride (USAN) |
(P) unclassified |
| D11616 |
Aspirin and omeprazole; Yosprala (TN) |
(P) unclassified |
| D11617 |
Eletriptan hydrobromide monohydrate |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11619 |
Desvenlafaxine succinate anhydrous; Desvenlafaxine succinate (TN) |
(P) unclassified |
| D11628 |
Benzhydrocodone and acetaminophen; Apadaz (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11631 |
Lefamulin (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11632 |
Lefamulin acetate (USAN); Xenleta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11652 |
Tenapanor (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11653 |
Tenapanor hydrochloride (JAN/USAN); Ibsrela (TN); Phozevel (TN); Xphozah (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11656 |
Azelastine hydrochloride and fluticasone propionate; Dymista (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11659 |
Tolvaptan sodium phosphate (JAN); Samtasu (TN) |
(P) unclassified |
| D11662 |
Valemetostat tosilate (JAN); Valemetostat tosylate; Ezharmia (TN) |
(P) unclassified |
| D11671 |
Elacestrant (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11672 |
Elacestrant hydrochloride (USAN); Elacestrant dihydrochloride; Orserdu (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11674 |
Berotralstat hydrochloride (JAN/USAN); Orladeyo (TN) |
(P) CYP inhibition: CYP3A4 |
| D11706 |
Omeprazole and sodium bicarbonate; Zegerid (TN) |
(P) unclassified |
| D11710 |
Phentermine and topiramate; Qsymia (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11711 |
Dapagliflozin, metformin and saxagliptin; Qternmet xr (TN) |
(P) unclassified |
| D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11717 |
Tepotinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11725 |
Futibatinib (JAN/USAN/INN); Lytgobi (TN) |
(P) unclassified |
| D11757 |
Inebilizumab (USAN/INN); Inebilizumab (genetical recombination) (JAN); Inebilizumab-cdon; Uplizna (TN) |
(P) unclassified |
| D11768 |
Pacritinib (USAN/INN); Vonjo (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11784 |
Vonoprazan (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11785 |
Oteseconazole (USAN/INN); Vivijoa (TN) |
(P) unclassified |
| D11793 |
Zuranolone (JAN/USAN/INN); Zurzuvae (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
| D11807 |
Imeglimin hydrochloride (JAN); Twymeeg (TN) |
(P) unclassified |
| D11816 |
Belumosudil mesylate (USAN); Belumosudil mesilate (JAN); Rezurock (TN) |
(P) unclassified |
| D11851 |
Butalbital, acetaminophen, caffeine and codeine phosphate |
(P) unclassified |
| D11856 |
Empagliflozin, linagliptin and metformin hydrochloride; Trijardy xr (TN) |
(P) unclassified |
| D11860 |
Butalbital, aspirin, caffeine and codeine; Fiorinal with codeine (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11861 |
Indacaterol acetate, glycopyrronium bromide and mometasone furoate; Enerzair (TN) |
(P) unclassified |
| D11862 |
Indacaterol and mometasone furoate; Atectura (TN) |
(P) unclassified |
| D11863 |
Human papillomavirus 9-valent vaccine, recombinant; Recombinant adsorbed 9-valent human papillomavirus virus-like particle vaccine (yeast origin); Gardasil 9 (TN); Silgard 9 (TN) |
(P) unclassified |
| D11881 |
Amlodipine benzoate; Katerzia (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11886 |
Daridorexant (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11910 |
Danuglipron (USAN) |
(P) unclassified |
| D11911 |
Danuglipron tromethamine (USAN) |
(P) unclassified |
| D11920 |
Pimitespib (JAN); Jeselhy (TN) |
(P) unclassified |
| D11923 |
Lobeglitazone (INN) |
(P) unclassified |
| D11924 |
Beinaglutide (INN) |
(P) unclassified |
| D11954 |
Belzutifan (JAN/USAN/INN); Welireg (TN) |
(P) unclassified |
| D11968 |
Teneligliptin hydrobromide (JAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) unclassified |
| D12005 |
Treprostinil palmitil (USAN/INN) |
(P) unclassified |
| D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
| D12130 |
Drospirenone, ethinyl estradiol and levomefolate calcium; Beyaz (TN); Safyral (TN); Tydemy (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D12162 |
Lenacapavir sodium (JAN/USAN); Sunlenca (TN) |
(P) unclassified |
| D12205 |
Pneumococcal 15-valent conjugate vaccine; Vaxneuvance (TN) |
(P) unclassified |
| D12225 |
Mazdutide (USAN) |
(P) unclassified |
| D12265 |
Mavacamten (JAN/USAN/INN); Camzyos (TN) |
(P) unclassified |
| D12269 |
Nirmatrelvir and ritonavir; Paxlovid (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D12294 |
Sitagliptin phosphate (JAN) |
(P) unclassified |
| D12301 |
Adagrasib (USAN/INN); Krazati (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D12311 |
Bortezomib hydrate (JAN) |
(P) unclassified |
| D12312 |
Codeine phosphate and chlorpheniramine maleate; Tuxarin (TN) |
(P) unclassified |
| D12313 |
Chlorpheniramine polistirex and codeine polistirex; Tuzistra (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D12326 |
Opelconazole (USAN/INN) |
(P) unclassified |
| D12341 |
Vurolenatide (USAN/INN) |
(P) unclassified |
| D12353 |
Ensitrelvir fumarate (USAN); Ensitrelvir fumaric acid (JAN); Xocova (TN) |
(P) unclassified |
| D12358 |
Insulin icodec (USAN/INN); Insulin icodec (genetical recombination) (JAN) |
(P) unclassified |
| D12403 |
Venlafaxine besylate monohydrate; Venlafaxine besylate (TN) |
(P) unclassified |
| D12444 |
Nilotinib hydrochloride dihydrate (JAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D12446 |
Anpocogin (USAN) |
(P) unclassified |
| D12483 |
Olutasidenib (USAN/INN); Rezlidhia (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D12484 |
Carfloglitazar (INN) |
(P) unclassified |
| D12486 |
Finasteride and tadalafil; Entadfi (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D12497 |
Drospirenone and estradiol; Angeliq (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D12529 |
Orforglipron calcium (USAN) |
(P) unclassified |
| D12536 |
Orforglipron (USAN) |
(P) unclassified |
| D12544 |
Vortioxetine hemihydrobromide (USAN) |
(P) unclassified |
| D12555 |
Lotiglipron (USAN) |
(P) unclassified |
| D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(CI,P) unclassified |
| D12595 |
Aspirin trelamine (USAN) |
(P) unclassified |
| D12596 |
Aspirin trelamine hydrochloride (USAN) |
(P) unclassified |
| D12609 |
Dasatinib laurylsulfate (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D12629 |
Treprostinil phosphate (USAN); Treprostinil biphosphate |
(P) unclassified |
| D12637 |
Darunavir hydrate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D12703 |
Linagliptin hydrate (JAN); Linagliptin hemihydrate |
(P) unclassified |
| D12735 |
Lotiglipron tromethamine (USAN) |
(P) unclassified |
| D12752 |
Darunavir propylene glycolate |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D12756 |
Vonoprazan and amoxicillin; Voquezna (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D12816 |
Dexlansoprazole sesquihydrate |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D12854 |
Nilotinib laurylsulfate (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D12861 |
Pemvidutide (USAN/INN) |
(P) unclassified |
| D12874 |
Live attenuated influenza virus vaccine, intranasal; Flumist (TN) |
(CI) unclassified |
